SABLE OFFSHORE CORP., S-1 filed on 2/14/2024
Securities Registration Statement
v3.24.0.1
Cover Page
9 Months Ended
Sep. 30, 2023
Document Information [Line Items]  
Document Type S-1
Amendment Flag false
Entity Registrant Name Sable Offshore Corp.
Entity Central Index Key 0001831481
Entity Address, State or Province TX
Entity Incorporation, State or Country Code DE
Entity Primary SIC Number 1311
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company true
Entity Small Business true
Entity Ex Transition Period false
Entity Address, Address Line One 700 Milam Street, Suite 3300
Entity Address, City or Town Houston
Entity Address, Postal Zip Code 77002
Entity Tax Identification Number 85-3514078
City Area Code 713
Local Phone Number 579-6106
Business Contact [Member]  
Document Information [Line Items]  
Entity Address, State or Province TX
Contact Personnel Name Gregory D. Patrinely
Entity Address, Address Line One 700 Milam Street, Suite 3300
Entity Address, City or Town Houston
Entity Address, Postal Zip Code 77002
City Area Code 713
Local Phone Number 579-6106
v3.24.0.1
Condensed Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Current assets:      
Cash $ 709,450 $ 100,256 $ 322,768
Prepaid expenses 246,392 88,212 521,878
Total current assets 955,842 188,468 844,646
Prepaid expenses - non-current   0 78,630
Investment held in Trust Account 63,939,672 290,718,297 287,516,153
Total assets 64,895,514 290,906,765 288,439,429
Current liabilities:      
Accounts payable and accrued expenses 6,153,608 4,625,892 275,500
Excise tax payable 2,308,378 0  
Income taxes payable 785,543 330,151 0
Promissory notes to related parties 1,128,630 370,000 0
Convertible promissory notes – related parties, at fair value 2,645,096 1,409,730 956,115
Total current liabilities 13,021,255 6,735,773 1,231,615
Warrant liabilities 15,154,125 12,149,250 12,647,250
Total liabilities 28,175,380 18,885,023 13,878,865
Commitments and Contingencies
Class A common stock subject to possible redemption; 6,104,682 and 28,750,000 shares at redemption value at September 30, 2023 and December 31, 2022, respectively ($10.34 and $10.10 at September 30, 2023 and December 31, 2022) 63,123,555 290,347,008 287,500,000
Stockholders' Deficit:      
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital 0 0  
Accumulated deficit (26,404,140) (18,325,985) (12,940,155)
Total Stockholders' Deficit (26,403,421) (18,325,266) (12,939,436)
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders' Deficit 64,895,514 290,906,765 288,439,429
Common Class A [Member]      
Stockholders' Deficit:      
Common Stock, Value 719
Common Class B [Member]      
Stockholders' Deficit:      
Common Stock, Value $ 719 $ 719
v3.24.0.1
Condensed Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2023
Aug. 31, 2023
Aug. 29, 2023
Jun. 30, 2023
Mar. 02, 2023
Feb. 27, 2023
Feb. 23, 2023
Dec. 31, 2022
Dec. 31, 2021
Temporary equity shares outstanding 6,104,682             28,750,000 28,750,000
Preferred stock par or stated value per share $ 0.0001             $ 0.0001 $ 0.0001
Preferred stock shares authorized 1,000,000             1,000,000 1,000,000
Preferred stock shares issued 0             0 0
Preferred stock shares outstanding 0             0 0
Temporary Equity Redemption Price Per Share   $ 10.31 $ 10.31   $ 10.15        
Common Class A [Member]                  
Temporary equity shares outstanding 6,104,682   2,328,063 8,432,745   20,317,255 20,317,255 28,750,000 28,750,000
Common stock par or stated value per share $ 0.0001             $ 0.0001 $ 0.0001
Common stock shares authorized 200,000,000             200,000,000 200,000,000
Common stock shares issued 7,187,500             0 0
Common stock shares outstanding 7,187,500             0 0
Temporary Equity Redemption Price Per Share $ 10.34             $ 10.1 $ 10
Common Class B [Member]                  
Common stock par or stated value per share $ 0.0001             $ 0.0001 $ 0.0001
Common stock shares authorized 20,000,000             20,000,000 20,000,000
Common stock shares issued 0             7,187,500 7,187,500
Common stock shares outstanding 0             7,187,500 7,187,500
v3.24.0.1
Condensed Statements of Operations - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Operating costs $ 996,938 $ 1,281,508 $ 3,485,342 $ 2,012,339 $ 6,150,199 $ 1,682,816
Loss from operations (996,938) (1,281,508) (3,485,342) (2,012,339) (6,150,199) (1,682,816)
Other income (expense):            
Interest income from Trust Account 699,906 1,245,964 3,840,682 1,615,323 3,989,061 16,153
Initial fair value adjustment of promissory note         0 (18,323)
Change in fair value of convertible promissory notes – related parties (757,488) 1,200 37,804 (21,011) (170,741) 83,768
Change in fair value of warrant liabilities (9,271,875) 372,750 (3,004,875) 10,003,125 498,000 6,155,125
Offering costs allocated to warrant         0 (280,829)
Total other (loss) income, net (9,329,457) 1,619,914 873,611 11,597,437 4,316,320 5,955,894
(Loss) income before income taxes (10,326,395) 338,406 (2,611,731) 9,585,098 (1,833,879) 4,273,078
Income tax expense (146,980) (530,156) (785,543) (530,156) (757,069) 0
Net (loss) income $ (10,473,375) $ (191,750) $ (3,397,274) $ 9,054,942 $ (2,590,948) $ 4,273,078
Redeemable Class A Common Stock [Member]            
Other income (expense):            
Weighted average shares outstanding, basic 8,169,859 28,750,000 12,660,640 28,750,000 28,750,000 24,417,808
Weighted average shares outstanding, diluted 8,169,859 28,750,000 12,660,640 28,750,000 28,750,000 24,417,808
Basic, net (loss) income per share $ (0.68) $ (0.01) $ (0.17) $ 0.25 $ (0.07) $ 0.14
Diluted, net (loss) income per share $ (0.68) $ (0.01) $ (0.17) $ 0.25 $ (0.07) $ 0.14
Non Redeemable Class B Common Stock [Member]            
Other income (expense):            
Weighted average shares outstanding, basic         7,187,500 7,187,500
Weighted average shares outstanding, diluted         7,187,500 7,187,500
Basic, net (loss) income per share         $ (0.07) $ 0.14
Diluted, net (loss) income per share         $ (0.07) $ 0.14
Non Redeemable Class A And Class B Common Stock [Member]            
Other income (expense):            
Weighted average shares outstanding, basic 7,187,500 7,187,500 7,187,500 7,187,500    
Weighted average shares outstanding, diluted 7,187,500   7,187,500 7,187,500    
Basic, net (loss) income per share $ (0.68) $ (0.01) $ (0.17) $ 0.25    
Diluted, net (loss) income per share $ (0.68) $ (0.01) $ (0.17) $ 0.25    
v3.24.0.1
Condensed Statements of Changes In Stockholders' Deficit - USD ($)
Total
Private Placement Warrants [Member]
Common Stock [Member]
Common Class A [Member]
Common Stock [Member]
Common Class B [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Private Placement Warrants [Member]
Accumulated Deficit [Member]
Balance at Dec. 31, 2020 $ 23,343   $ 0 $ 719 $ 24,281   $ (1,657)
Balance (Shares) at Dec. 31, 2020     0 7,187,500      
Initial fair value adjustment of convertible promissory notes – related parties 143,440           143,440
Remeasurement of Class A common stock subject to possible redemption (18,545,672)       (1,190,656)   (17,355,016)
Proceeds received in excess of initial fair value of Private Placement Warrants   $ 1,166,375       $ 1,166,375  
Net (loss) income 4,273,078           4,273,078
Balance at Dec. 31, 2021 (12,939,436)   $ 0 $ 719 0   (12,940,155)
Balance (Shares) at Dec. 31, 2021     0 7,187,500      
Initial fair value adjustment of convertible promissory notes – related parties 52,126           52,126
Net (loss) income 6,421,767           6,421,767
Balance at Mar. 31, 2022 (6,465,543)   $ 0 $ 719 0   (6,466,262)
Balance (Shares) at Mar. 31, 2022     0 7,187,500      
Balance at Dec. 31, 2021 (12,939,436)   $ 0 $ 719 0   (12,940,155)
Balance (Shares) at Dec. 31, 2021     0 7,187,500      
Remeasurement of Class A common stock subject to possible redemption (750,183)            
Net (loss) income 9,054,942            
Balance at Sep. 30, 2022 (4,582,551)   $ 0 $ 719 0   (4,583,270)
Balance (Shares) at Sep. 30, 2022     0 7,187,500      
Balance at Dec. 31, 2021 (12,939,436)   $ 0 $ 719 0   (12,940,155)
Balance (Shares) at Dec. 31, 2021     0 7,187,500      
Initial fair value adjustment of convertible promissory notes – related parties 52,126           52,126
Remeasurement of Class A common stock subject to possible redemption (2,847,008)       0   (2,847,008)
Net (loss) income (2,590,948)           (2,590,948)
Balance at Dec. 31, 2022 (18,325,266)   $ 0 $ 719 0   (18,325,985)
Balance (Shares) at Dec. 31, 2022     0 7,187,500      
Balance at Mar. 31, 2022 (6,465,543)   $ 0 $ 719 0   (6,466,262)
Balance (Shares) at Mar. 31, 2022     0 7,187,500      
Remeasurement of Class A common stock subject to possible redemption (84,375)           (84,375)
Net (loss) income 2,824,925           2,824,925
Balance at Jun. 30, 2022 (3,724,993)   $ 0 $ 719 0   (3,725,712)
Balance (Shares) at Jun. 30, 2022     0 7,187,500      
Remeasurement of Class A common stock subject to possible redemption (665,808)           (665,808)
Net (loss) income (191,750)           (191,750)
Balance at Sep. 30, 2022 (4,582,551)   $ 0 $ 719 0   (4,583,270)
Balance (Shares) at Sep. 30, 2022     0 7,187,500      
Balance at Dec. 31, 2022 (18,325,266)   $ 0 $ 719 0   (18,325,985)
Balance (Shares) at Dec. 31, 2022     0 7,187,500      
Initial fair value adjustment of convertible promissory notes – related parties 42,205           42,205
Remeasurement of Class A common stock subject to possible redemption (1,776,354)           (1,776,354)
Excise tax on Class A common stock redemptions (2,068,297)           (2,068,297)
Net (loss) income 2,036,482           2,036,482
Balance at Mar. 31, 2023 (20,091,230)   $ 0 $ 719 0   (20,091,949)
Balance (Shares) at Mar. 31, 2023     0 7,187,500      
Balance at Dec. 31, 2022 (18,325,266)   $ 0 $ 719 0   (18,325,985)
Balance (Shares) at Dec. 31, 2022     0 7,187,500      
Remeasurement of Class A common stock subject to possible redemption (2,905,703)            
Net (loss) income (3,397,274)            
Balance at Sep. 30, 2023 (26,403,421)   $ 719 $ 0 0   (26,404,140)
Balance (Shares) at Sep. 30, 2023     7,187,500 0      
Balance at Mar. 31, 2023 (20,091,230)   $ 0 $ 719 0   (20,091,949)
Balance (Shares) at Mar. 31, 2023     0 7,187,500      
Initial fair value adjustment of convertible promissory notes – related parties 186,194           186,194
Remeasurement of Class A common stock subject to possible redemption (626,422)           (626,422)
Net (loss) income 5,039,619           5,039,619
Balance at Jun. 30, 2023 (15,491,839)   $ 0 $ 719 0   (15,492,558)
Balance (Shares) at Jun. 30, 2023     0 7,187,500      
Initial fair value adjustment of convertible promissory notes – related parties 304,801           304,801
Remeasurement of Class A common stock subject to possible redemption (502,927)           (502,927)
Conversion of Class B common stock to Class A common stock     $ 719 $ (719)      
Conversion of Class B common stock to Class A common stock (Shares)     7,187,500 (7,187,500)      
Excise tax on Class A common stock redemptions (240,081)           (240,081)
Net (loss) income (10,473,375)           (10,473,375)
Balance at Sep. 30, 2023 $ (26,403,421)   $ 719 $ 0 $ 0   $ (26,404,140)
Balance (Shares) at Sep. 30, 2023     7,187,500 0      
v3.24.0.1
Condensed Statements of Cash Flows - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:        
Net (loss) income $ (3,397,274) $ 9,054,942 $ (2,590,948) $ 4,273,078
Adjustments to reconcile net income to net cash used in operating activities:        
Interest income from Trust Account (3,840,682) (1,615,323) (3,989,061) (16,153)
Initial fair value adjustment of promissory note     0 18,323
Change in fair value of convertible promissory notes – related parties (37,804) 21,011 170,741 (83,768)
Change in fair value of warrant liabilities 3,004,875 (10,003,125) (498,000) (6,155,125)
Offering costs allocated to warrants     0 280,829
Changes in current assets and current liabilities:        
Prepaid expenses (158,180) 362,012 512,296 (600,508)
Accounts payable and accrued expenses 1,527,716 812,797 4,350,391 275,500
Income taxes payable 455,392 530,156 330,151 0
Net cash used in operating activities (2,445,957) (837,530) (1,714,430) (2,007,824)
Cash flows from investing activities:        
Investment of cash into Trust Account     0 (287,500,000)
Cash withdrawn from Trust Account in connection with redemptions 230,129,156 0 786,918 0
Cash Withdrawn From Trust Accounts To Pay Taxes 490,151 320,000    
Net cash provided by investing activities 230,619,307 320,000 786,918 (287,500,000)
Cash flows from financing activities:        
Payments for redemptions of Class A common stock (230,129,156) 0    
Proceeds from convertible promissory notes – related parties 1,080,000 335,000    
Proceeds from Initial Public Offering, net of underwriters' discount     0 281,750,000
Proceeds from issuance of Private Placement Warrants     0 7,750,000
Proceeds from promissory notes – related parties 1,485,000 0 705,000 1,196,548
Proceeds from convertible promissory notes – related parties     0 (75,174)
Payments of offering costs     0 (799,796)
Net cash (used in) provided by financing activities (227,564,156) 335,000 705,000 289,821,578
Net Change in Cash 609,194 (182,530) (222,512) 313,754
Cash, beginning of the period 100,256 322,768 322,768 9,014
Cash, end of the period 709,450 140,238 100,256 322,768
Supplemental disclosure of noncash investing and financing activities        
Conversion of Promissory Notes to Convertible Promissory Notes 726,370 0    
Initial value of Class A common stock subject to possible redemption     0 268,954,328
Initial measurement of fair value of Convertible Promissory Notes (533,200) (52,126) (52,126) (143,440)
Remeasurement of Class A common stock subject to possible redemption 2,905,703 750,183 2,847,008 18,545,672
Initial fair value of warrant liabilities     0 18,802,375
Excise tax payable as a result of redemptions of Class A common stock 2,308,378 0    
Supplemental Disclosure of Cash Flow Information:        
Payment of cash taxes $ 330,151 $ 0 $ 426,918 $ 0
v3.24.0.1
Organization, and Business Operations
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Organization, and Business Operations
Note 1 — Organization, and Business Operations
Organization and General
Flame Acquisition Corp. (the “Company”) was incorporated in Delaware on October 16, 2020. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company has selected December 31 as its fiscal year end.
On November 2, 2022, the Company entered into an agreement and plan of merger, dated as of November 2, 2022 (as it may be amended, supplemented, or otherwise modified from time to time, the “Merger Agreement”), with Sable Offshore Corp., a Texas corporation (“SOC”), and Sable Offshore Holdings, LLC, a Delaware limited liability company and the parent company of SOC (“Holdco” and, together with SOC, “Sable”), as fully disclosed in the Current Report on Form
8-K
filed by the Company with the U.S Securities and Exchange Commission (“SEC”) on November 2, 2022. The Merger Agreement provides for, among other things, the following transactions at the closing: (i) Holdco will merge with and into the Company, with the Company surviving the merger (the “Holdco Merger”), and (ii) immediately following the effective time of the Holdco Merger, SOC will merge with and into the Company, with the Company surviving the merger (the “SOC Merger”). The Holdco Merger together with the SOC Merger are referred to as the “Merger,” and the Merger and other transactions contemplated by the Merger Agreement are referred to as the “Business Combination.” In connection with the Business Combination, the Company will change its name to Sable Offshore Corp. The independent members of the board of directors of the Company (the “Board”) approved, and recommended that the Board approve, the Merger Agreement and the transactions contemplated thereby. Subsequently, the Board approved the Merger Agreement and the transactions contemplated thereby.
The obligations of the parties to consummate the Business Combination are subject to the satisfaction or waiver of certain customary closing conditions. The closing of the Merger is expected to occur on the third business day after the satisfaction or waiver (if legally permissible) of the conditions set forth in the Merger Agreement, except as otherwise mutually agreed by the parties. The Merger Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing and the Company can provide no assurance that the Business Combination will be consummated at the expected time, or at all.
In connection with the Business Combination, Holdco entered into subscription agreements (the “Sable PIPE Subscription Agreements”) with certain investors (the “Sable PIPE Investors”), pursuant to which the Sable PIPE Investors agreed to purchase, in the aggregate, 7,450,000 limited liability company membership interests in Holdco designated as Class B shares at $10.00 per share, for an aggregate commitment amount of approximately $74,500,000 (the “Sable PIPE Investment”).
The Sable PIPE Subscription Agreements provide that, in the event the Merger is consummated, the Sable PIPE Investors will be deemed to have subscribed for and will purchase our Class A common stock at the same price per share and, by operation of law pursuant to the Merger, the Company will have succeeded to Holdco’s obligations under the Sable PIPE Subscription Agreements. The Sable PIPE Subscription Agreements provide that, if the Merger is consummated, we must file a registration statement within 30 calendar days after consummation of the Merger registering the resale of the shares of our Class A common stock issued to the Sable PIPE Investors, and must use our commercially reasonable efforts to have the registration statement declared effective by the SEC by the earlier of (i) the 90th calendar day (or 120th calendar day if the SEC notifies us that
it will review the registration statement) following the closing of the Merger and (ii) the 10th business day after the date we are notified (orally or in writing, whichever is earlier) by the SEC that the registration statement will not be reviewed or will not be subject to further review. We thereafter will be required to maintain a registration statement that is continuously effective and to cause the registration statement to regain effectiveness in the event that it ceases to be effective.
On November 10, 2022, the Company filed a preliminary proxy statement relating to the Business Combination (as amended, the “Proxy Statement”), which included a recommendation of the Board to the Company’s stockholders that they approve the proposals included in the Proxy Statement. The Company also filed amended preliminary proxy statements on December 23, 2022, January 27, 2023 and September 14, 2023 for the purpose of addressing SEC Staff comments.
On February 27, 2023, at a special meeting of stockholders, the Company’s stockholders voted to approve an amendment (the “First Extension Amendment Proposal”) to the amended and restated certificate of incorporation to extend the date by which the Company must complete a business combination (the “First Extension”) from March 1, 2023, to September 1, 2023 (the “First Extended Date”). In connection with the First Extension, stockholders holding 20,317,255 shares of Class A common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account, representing approximately 70.67% of our
then
issued and outstanding Class A common stock. As a result, $206,121,060 (approximately $10.15 per share) was removed from the Trust Account to pay such redeeming holders on March 2, 2023.
On June 13, 2023, Sable, Exxon Mobil Corporation (“Exxon”) and Mobil Pacific Pipeline Company (“MPPC,” and together with Exxon, “EM”) entered into a First Amendment (the “Amendment”) to the Purchase and Sale Agreement dated November 1, 2022 among Sable and EM. Pursuant to the Amendment, Sable and EM agreed to amend the
Sable-EM
Purchase Agreement to, among other things, provide that the closing of the transactions contemplated by the
Sable-EM
Purchase Agreement was scheduled to take place on June 30, 2023 (the
“Sable-EM
Scheduled Closing Date”), unless one or more of the conditions to closing described in the
Sable-EM
Purchase Agreement was not satisfied as of the
Sable-EM
Scheduled Closing Date, in which case the closing would be held three business days after all such conditions were satisfied or waived, or such other date as the parties may mutually agree in writing, but in no event later than December 31, 2023. The Amendment also lowers the “Minimum Cash Threshold” (as defined in the
Sable-EM
Purchase Agreement) from $
200,000,000
to $
150,000,000
.

On June 30, 2023, the Company and Sable entered into a Second Amendment to the Merger Agreement, pursuant to which the parties agreed to extend the date by which the parties must consummate the Business Combination, or otherwise either Flame or Sable may terminate the Merger Agreement, from June 30, 2023, to March 1, 2024.
On August 22, 2023, we issued an aggregate of 7,187,500 shares of Class A common stock to the Sponsor, FL
Co-Investment,
Intrepid Financial Partners, our independent directors and certain of our executive officers, upon the conversion of an equal number of shares of Class B common stock (the “Class B Conversion”). The 7,187,500 shares of Class A common stock issued in connection with the Class B Conversion are subject to the same restrictions as applied to the shares of Class B common stock before the Class B Conversion, including, among other things, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination, as described in the prospectus for the Initial Public Offering (“IPO”) described below. After the Class B Conversion, no shares of Class B common stock remained outstanding.
On August 29, 2023, at a special meeting of stockholders, the Company’s stockholders voted to approve a proposal (the “Second Extension Amendment Proposal”) to amend the amended and restated certificate of incorporation to extend the date by which the Company must complete a business combination (the “Second Extension”) from September 1, 2023, to March 1, 2024 (the “Second Extension Amendment”). In connection with the Second Extension, stockholders holding 2,328,063 shares of Class A common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account, representing approximately
27.61% of our
then
issued and outstanding Class A common stock. As a result, $24,008,096 (approximately $10.31 per share) was removed from the Trust Account to pay such redeeming holders on August 31, 2023.
On August 29, 2023, in connection with the Second Extension, we filed the Second Extension Amendment to the Company’s amended and restated certificate of incorporation with the Secretary of State of the State of Delaware. The Second Extension Amendment extends the date by which we must consummate our initial business combination from September 1, 2023 to March 1, 2024.
As of September 30, 2023, the Company had not yet commenced any operations. All activity through September 30, 2023 relates to the Company’s formation, the IPO and, since the closing of the IPO, the search for a target for our initial Business Combination, and since the signing of the Merger Agreement, completing our initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO and
non-operating
income or expense from changes in the fair value of warrant liabilities and convertible promissory notes.
Financing
The registration statement for the Company’s IPO was declared effective on February 24, 2021 (the “Effective Date”). On March 1, 2021, the Company consummated the IPO of 28,750,000 units (the “Units” and, with respect to the common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $287,500,000, which is discussed in Note 3.
Simultaneously with the closing of the IPO, the Company consummated the sale of 7,750,000 warrants (the “Private Placement Warrants”), at a price of $1.00 per Private Placement Warrant, which is discussed in Note 4.
Trust Account
Following the closing of the IPO on March 1, 2021, an amount of $287,500,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (“Trust Account”) which is invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185
days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company. However, to mitigate the risk of our being deemed to be an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act) and thus subject to regulation under the Investment Company Act, on February 21, 2023, we instructed American Stock Transfer & Trust Company, the trustee with respect to the Trust Account, to liquidate the investments previously held in the Trust Account and to hold all funds in the Trust Account in cash (which may include an interest bearing demand deposit account at a national bank) until the earlier of the consummation of our initial business combination or the liquidation of the Company. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its tax obligations (see Note 2), the proceeds from the IPO and the sale of the Private Placement Warrants will not be released from the Trust Account until the earliest of (a) the completion of the Company’s initial business combination, (b) the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation, and (c) the redemption of the Company’s Public Shares if the Company is unable to complete the initial business combination by March 1, 2024, subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholders. 
Initial Business Combination
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to be generally applied toward consummating a business combination.
The Company’s business combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (net of taxes payable) at the time of the signing of an agreement to enter into a business combination. However, the Company will only complete a business combination if the post-business combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a business combination.
The Company will provide its public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the initial business combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).
The shares of common stock subject to redemption are recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). The Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.
The Company has until March 1, 2024 to consummate a business combination (the “Combination Period”). However, if the Company is unable to complete a business combination within the Combination Period, the Company will redeem 100% of the outstanding Public Shares for a pro rata portion of the funds held in the Trust Account, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company for the payment of taxes, and less up to $100,000 of interest to pay dissolution expenses, divided by the number of then outstanding Public Shares, subject to applicable law, and then seek to dissolve and liquidate.
Flame Acquisition Sponsor, LLC a Delaware company (the “Sponsor”), and the Company’s officers and directors have agreed to (i) waive their redemption rights with respect to their Founder Shares (see Note 5), Private Placement Warrants and Public Shares in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation, and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares and Private Placement Warrants if the Company fails to complete the initial business combination within the Combination Period.
The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if
less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification obligations. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot be certain that the Sponsor would be able to satisfy those obligations.
Going Concern
As of September 30, 2023, the Company had cash outside the Trust Account of $709,450 available for working capital needs and a working capital deficit of $12,065,413. All remaining cash held in the Trust Account is generally unavailable for the Company’s use, prior to an initial business combination, and is restricted for use either in a Business Combination, to redeem common stock or to use for payment of taxes. As of September 30, 2023, $816,118 of the amount in the Trust Account was available to be withdrawn as described above.
Through September 30, 2023, the Company’s liquidity needs have been satisfied through various promissory notes from its sponsor (see further discussion of the individual promissory notes in Note 5).
Until consummation of its Business Combination, the Company will be using the funds not held in the Trust Account, and any additional Working Capital Loans (as defined in Note 5) from the initial stockholders, the Company’s officers and directors, or their respective affiliates (which is described in Note 5), for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination.
If the Company’s estimates of the costs of undertaking
in-depth
due diligence and negotiating a business combination are less than the actual amounts necessary to do so, the Company may have insufficient funds available to operate its business prior to the business combination and will need to raise additional capital through loans from the Sponsor, its officers and/or directors, or third parties. Except as contemplated by the terms of the Working Capital Loans, neither the Sponsor nor the Company’s officers or directors are under any obligation to advance additional funds to, or to invest in, the Company (see Note 5). If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of its business plan, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. The Company is also subject to a mandatory liquidation and subsequent dissolution requirement if it does not complete its initial business combination by March 1, 2024. In connection with the Company’s assessment of going concern considerations in accordance with ASC Subtopic
205-40,
Presentation of Financial Statements - Going Concern, the Company cannot assure you that its plans to raise capital or to consummate an initial business combination before March 1, 2024 will be successful. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
Risks and Uncertainties
Management continues to evaluate the impact of the
COVID-19
pandemic and the conflict in Ukraine and the surrounding region, and has concluded that while it is reasonably possible that these risks and uncertainties could
have a negative effect on the Company’s financial position, results of operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of these uncertainties.
Inflation Reduction Act of 2022
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from whom shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases made during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “U.S. Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.
Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the U.S. Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.
The Company determined that the $
230,129,156
in Trust Account value relating to the Class A common stock redeemed during the nine months ended September 30, 2023 (as noted above) is currently subject to the excise tax. Accordingly, an excise tax payable of $
2,308,378
was recognized upon the redemptions and was recorded as a liability on the condensed balance sheet and as a charge to Accumulated Deficit. The Company will continue to assess the excise tax payable recognizing an additional excise tax liability for any future stock repurchases/redemptions and netting such liability for any future qualifying stock issuances within the same annual period.
NOTE 1 — ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN
Organization and General
Flame Acquisition Corp. (the “Company”) was incorporated in Delaware on October 16, 2020. The
Company
was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company has selected December 31 as its fiscal year end.
On November 2, 2022, the Company entered into an agreement and plan of merger, dated as of November 2, 2022 (as it may be amended, supplemented, or otherwise modified from time to time, the “Merger Agreement”), with Sable Offshore Corp., a Texas corporation (“SOC”), and Sable Offshore Holdings, LLC, a Delaware limited liability company and the parent company of SOC (“Holdco” and, together with SOC, “Sable”), as fully disclosed in the Current Report on Form
8-K
filed by the Company with the SEC on November 2, 2022. The Merger Agreement provides for, among other things, the following transactions at the closing: (i) Holdco will merge with and into the Company, with the Company surviving the merger (the “Holdco Merger”), and (ii) immediately following the effective time of the Holdco Merger, SOC will merge with and into the Company, with the Company surviving the merger (the “SOC Merger”). The Holdco Merger together with the SOC Merger are referred to as the “Merger,” and the Merger and other transactions contemplated by the Merger Agreement are referred to as the “Business Combination.” In connection with the Business Combination, the Company will change its name to Sable Offshore Corp. The independent members of the board of directors of the Company (the “Board”) approved, and recommended that the Board approve, the Merger Agreement and the transactions contemplated thereby. Subsequently, the Board approved the Merger Agreement and the transactions contemplated thereby.
The obligations of the parties to consummate the Business Combination are subject to the satisfaction or waiver of certain customary closing conditions. The closing of the Merger is expected to occur on the third business day after the satisfaction or waiver (if legally permissible) of the conditions set forth in the Merger Agreement, except as otherwise mutually agreed by the parties. The Merger Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing and the Company can provide no assurance that the Business Combination will be consummated at the expected time, or at
all.
In connection
with
the Business Combination, Holdco entered into subscription agreements (the “Sable PIPE Subscription Agreements”) with certain investors (such investors, the “Sable PIPE Investors”), pursuant to which the Sable PIPE Investors agreed to purchase, in the aggregate, 7,450,000 limited liability company membership interests in Holdco designated as Class B shares at $10.00 per share, for an aggregate commitment amount of approximately $74,500,000 (the “Sable PIPE Investment”).
The Sable PIPE Subscription Agreements provide that, in the event the Merger is consummated, the Sable PIPE Investors will be deemed to have subscribed for and will purchase our Class A common stock at the same price per share and, by operation of law pursuant to the Merger, we will have succeeded to Holdco’s obligations under the Sable PIPE Subscription Agreements. The Sable PIPE Subscription Agreements provide that, if the Merger is consummated, we must file a registration statement within 30 calendar days after consummation of the Merger registering the resale of the shares of our Class A common stock issued to the Sable PIPE Investors, and must use our commercially reasonable efforts to have the registration statement declared effective by the SEC by the earlier of (i) the 90th calendar day (or 120th calendar day if the SEC notifies us that it will review the registration
statement) following the closing of the Merger and (ii) the 10th business day after the date we are notified (orally or in writing, whichever is earlier) by the SEC that the registration statement will not be reviewed or will not be subject to further review. We thereafter will be required to maintain a registration statement that is continuously effective and to cause the registration statement to regain effectiveness in the event that it ceases to be effective.
The foregoing description of the Sable PIPE Subscription Agreements does not purport to be complete and is qualified in its entirety by reference to the full text of the form Sable PIPE Subscription Agreement filed as an exhibit to our Current Report on Form 8-K, filed with the SEC on November 2, 2022.
On November 10, 2022, the Company filed a preliminary proxy statement relating to the Business Combination (as amended, the “Proxy Statement”), which included a recommendation of the Board to the Company’s stockholders that they approve the proposals included in the Proxy Statement. The Company also filed amended preliminary proxy statements on December 23, 2022 and January 27, 2023 for the purpose of addressing U.S. Securities and Exchange Commission Staff comments.
As of December 31, 2022, the Company had not yet commenced any operations. All activity through December 31, 2022 relates to the Company’s formation, the Initial Public Offering (“IPO”) described below and, since the closing of the IPO, the search for a target for our initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO and
non-operating
income or expense from changes in the fair value of warrant liabilities and
convertible
promissory notes.
Financing
The registration statement for the Company’s IPO was declared effective on February 24, 2021 (the “Effective Date”). On March 1, 2021, the Company consummated the IPO of 28,750,000 units (the “Units” and, with respect to the common stock included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $287,500,000, which is discussed in Note 3.
Simultaneously with the closing of the IPO, the Company consummated the sale of 7,750,000 warrants (the “Private Placement Warrants”), at a price of $1.00 per Private Placement Warrant, which is discussed in Note 4.
Transaction costs amounted to $6,607,751 consisting of $5,750,000 of underwriting fees and $857,751 of other offering costs. Of the total transaction costs, $280,829 was allocated to expense as
non-operating
expense in the statement of operations for the year ended December 31, 2021 with the rest of the offering costs allocated among common stock subject to possible redemption and stockholders’ deficit. The transaction costs were allocated based on the with and without method, compared to the total offering proceeds, between the fair value of the public warrant liabilities and the Class A common stock.
Trust Account
Following the closing of the IPO on March 1, 2021, an amount of $287,500,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (“Trust Account”) which is invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185
 
days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule
2a-7
of the Investment Company Act, as determined by the Company. However, to mitigate the risk of our being deemed to be an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act) and thus subject to regulation under the Investment Company Act,
on February 21, 2023,
we instructed American Stock Transfer & Trust Company, the trustee with respect to the Trust Account, to liquidate the investments previously held in the Trust Account and to hold all funds in the Trust Account in
cash (which may include an interest
bearing
demand deposit
account at a national bank)
until the earlier of the consummation of our initial business combination or the liquidation of the Company. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its tax obligations (see Note 2), the proceeds from the IPO and the sale of the Private Placement Warrants will not be released from the Trust Account until the earliest of (a) the completion of the Company’s initial business combination, (b) the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation, and (c) the redemption of the Company’s Public Shares if the Company is unable to complete the initial business combination within 24 months from the closing of the IPO (See Note 11 – Subsequent Events for further discussion of the extension from March 1, 2023 to September 1, 2023), subject to applicable law. The proceeds deposited in the
Trust Account
could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholders.
Initial Business Combination
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to be generally applied toward consummating a business combination.
The Company’s business combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (net of taxes payable) at the time of the signing of an agreement to enter into a business combination. However, the Company will only complete a business combination if the post-business combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a business combination.
The Company will provide its public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the initial business combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).
The shares of common stock subject to redemption are recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). The Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.
The Company has 24 months from the closing of the IPO (See Note 11 – Subsequent Events for further discussion of the extension from March 1, 2023 to September 1, 2023, with the ability to further extend with stockholder approval) to consummate a business combination (the “Combination Period”). However, if the Company is unable to complete a business combination within the Combination Period, the Company will redeem 100% of the outstanding Public Shares for a pro rata portion of the funds held in the Trust Account, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company for the payment of taxes, and less up to $100,000 of interest to pay dissolution expenses, divided by the number of then outstanding Public Shares, subject to applicable law, and then seek to dissolve and liquidate.
 
Flame Acquisition Sponsor, LLC a Delaware company (the “Sponsor”), and the Company’s officers and directors have agreed to (i) waive their redemption rights with respect to their Founder Shares (see Note 5), Private Placement Warrants and Public Shares in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation, and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares and Private Placement Warrants if the Company fails to complete the initial business combination within the Combination Period.
The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $
10.00
per Public Share and (ii) the actual amount per Public Share held in the trust account as of the date of the liquidation of the Trust Account, if less than $
10.00
per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification obligations. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot be certain that the Sponsor would be able to satisfy those obligations.
Going Concern
As of December 31, 2022, the Company had cash outside the Trust Account of $100,256 available for working capital needs and a working capital deficit of $6,547,305. All remaining cash held in the Trust Account is generally unavailable for the Company’s use, prior to an initial business combination, and is restricted for use either in a Business Combination, to redeem common stock or to use for payment of taxes. As of December 31, 2022, $3,218,297 of the amount in the Trust Account was available to be withdrawn as described above
, which is net of the amount
the Company withdrew
(
$786,918
)
for payment of taxes during the period ended December 31, 2022.
Through December 31, 2022, the Company’s liquidity needs were satisfied through receipt of $25,000 from the sale of the Founder Shares and the remaining net proceeds from the IPO and the sale of Private Placement Warrants, as well as $300,000 that was available under the Initial Promissory Note, $365,000 that was available under the First Working Capital Loan, $800,000 that was available under the Second Working Capital Loan, $335,000 that was available under the Third Working Capital Loan, $170,000 that was available under the Q3 2022 Promissory Note and $200,000 that was available under the Q4 2022 Promissory Note (see Note 5). As of December 31, 2022, each of the working capital loans and the Q3 2022 Promissory Note and the Q4 2022 Promissory Note were fully drawn down. On February 6, 2023, the Company issued an additional unsecured promissory note (“Q1 2023 Promissory Note”) in the principal amount of $535,000 to aid in its ongoing liquidity needs (see Note 11).
Until consummation of its Business Combination, the Company will be using the funds not held in the Trust Account, and any additional Working Capital Loans (as defined in Note 5) from the initial stockholders, the Company’s officers and directors, or their respective affiliates (which is described in Note 5), for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination.
 
If the Company’s estimates of the costs of undertaking
in-depth
due diligence and negotiating a business combination are less than the actual amounts necessary to do so, the Company may have insufficient funds available to operate its business prior to the business combination and will need to raise additional capital through loans from the Sponsor, its officers and/or directors, or third parties. Except as contemplated by the terms of the Initial Promissory Note, First Working Capital Loan, Second Working Capital Loan, Third Working Capital Loan, Q3 2022 Promissory Note, Q4 2022 Promissory Note, and Q1 2023 Promissory Note (
See Note 11
), neither the Sponsor nor the Company’s officers or directors are under any obligation to advance additional funds to, or to invest in, the Company (see Note 5). If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of its business plan, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. The Company is also subject to a mandatory liquidation and subsequent dissolution requirement if it does not complete its initial business combination by September 1, 2023. The Company cannot assure you that its plans to raise capital or to consummate an initial business combination before September 1, 2023 will be successful. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
Risks and Uncertainties
Management continues to evaluate the impact of the
COVID-19
pandemic and the conflict in Ukraine and the surrounding region, and has concluded that while it is reasonably possible that these risks and uncertainties could have a negative effect on the Company’s financial position, results of operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.
Inflation Reduction Act of 2022
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from whom shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases made during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “U.S. Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.
Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the U.S. Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand
to
complete a Business Combination and in the Company’s ability to complete a Business Combination.
v3.24.0.1
Significant Accounting Policies
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Accounting Policies [Abstract]    
Significant Accounting Policies
Note 2— Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form
10-Q
and Article 8 of Regulation
S-X
of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
 
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form
10-K
as filed with the SEC on March 31, 2023, as well as the Company’s Current Reports on Form
8-K.
The accompanying condensed balance sheet as of December 31, 2022 has been derived from our audited financial statements included in that Annual Report. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods.
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant accounting estimates include inputs utilized to fair value warrant liabilities and convertible promissory notes. Actual results could differ from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022, respectively.
Marketable Securities Held in Trust Account
At December 31, 2022, the Trust Account had $290,718,297 in marketable securities. As discussed in Note 1, during the nine months ended September 30, 2023, the investments previously held in the Trust Account were liquidated with all funds in the Trust Account to be held in cash (which may include an interest bearing demand deposit account). During the nine months ended September 30, 2023 and the year ended December 31, 2022, the Company withdrew $490,151 and $786,918, respectively, of interest income from the Trust Account to pay its tax obligations.
 
Additionally, as discussed further below, approximately $230.1 million was removed from the Trust Account to pay redeeming holders during the nine months ended September 30, 2023.

Marketable securities held in the Trust Account
are
classified as “Trading Securities” in accordance with ASC 320, “Investments – Debt Securities” and are reported at fair value with unrealized gains or losses included in earnings of the current period.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At September 30, 2023 and December 31, 2022, the Company did not experience losses on this account.
Common Stock Subject to Possible Redemption
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity. The Company’s redeemable Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of September 30, 2023 and December 31, 2022,
6,104,682 and 28,750,000
shares of Class A common stock subject to possible redemption, representing all outstanding shares of redeemable Class A common stock on those dates, are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets, respectively.
Under ASC
480-10-S99,
the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of our initial public offering, we recognized the remeasurement amount from initial book value to redemption amount, which, resulted in charges against additional
paid-in
capital (to the extent available) and accumulated deficit.
Amount remeasured in 2023 represents investment income accrued in the Trust Account during the period reduced by the amounts of Delaware franchise tax and income taxes paid and payable for 2021, 2022 and 2023, net of cash withdrawn from the Trust Account to pay these obligations.
On February 23, 2023, the Company was notified by stockholders holding 20,317,255 shares of Class A common stock that they exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $206,121,060 (approximately $10.15 per share) was removed from the Trust Account to pay such redeeming holders on March 2, 2023.
On August 29, 2023, the Company was notified by stockholders holding 2,328,063 shares of Class A common stock that they exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $24,008,096 (approximately $10.31 per share) was removed from the Trust Account to pay such redeeming holders on August 31, 2023.
 
At September 30, 2023 and December 31, 2022, the Class A common stock reflected in the condensed balance sheets is reconciled in the following table:
 
 
  
Shares
 
  
Value
 
Gross proceeds from Initial Public Offering
     28,750,000      $ 287,500,000  
Less:
                 
Common stock issuance costs
     —         (6,326,922
Proceeds allocated to public warrants
     —         (12,218,750
Plus:
                 
Remeasurement of Class A common stock subject to possible
redemption
     —         21,392,680  
    
 
 
    
 
 
 
Contingently redeemable common stock at December 31, 2022
  
 
28,750,000
 
  
 
290,347,008
 
Less:
                 
Redemptions of Class A common stock
     (22,645,318      (230,129,156
Plus:
                 
Remeasurement of Class A common stock subject to possible
redemption
     —         2,905,703  
    
 
 
    
 
 
 
Contingently redeemable Class A common stock at September 30, 2023
  
 
6,104,682
 
  
$
63,123,555
 
    
 
 
    
 
 
 
Class A Common Stock
On August 22, 2023, we issued an aggregate of 7,187,500 shares of Class A common stock to the Sponsor, FL
Co-Investment,
Intrepid Financial Partners, our independent directors and certain of our executive officers, upon the conversion of an equal number of shares of Class B common stock (the “Class B Conversion”). The 7,187,500 shares of Class A common stock issued in connection with the Class B Conversion are subject to the same restrictions as applied to the shares of Class B common stock before the Class B Conversion, including, among other things, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination, as described in the prospectus for the Initial Public Offering (“IPO”) described below. After the Class B Conversion, no shares of Class B common stock remained outstanding.
Net (Loss) Income Per Share of Common Stock
The Company complies with accounting and disclosure requirements of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260, “Earnings Per Share.” Net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of shares of common stock outstanding for the period. Subsequent remeasurement of the redeemable Class A common stock is excluded from (loss) income per share of common stock as the redemption value approximates fair value. Net (loss) income per share of common stock is computed by dividing the pro rata net (loss) income between the shares of Class A common stock and the shares of Class B common stock by the weighted average number of shares of common stock outstanding for each of the periods. The calculation of diluted (loss) income per share does not consider the effect of the warrants issued in connection with the IPO, as well as warrants issuable upon the exercise of the conversion option on outstanding working capital loans, since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable for
 
25,431,370
and 23,625,000 shares of Class A common stock in the aggregate as of September 30, 2023 and 2022, respectively.
 
The following table reflects the calculation of basic and diluted net (loss) income
per
share of common stock (in dollars, except share amounts):

 
    
For the Three Months Ended
September 30,
   
For the Nine Months Ended
September 30,
 
    
2023
   
2022
   
2023
   
2022
 
Common stock subject to possible redemption
        
Numerator:
        
Net (loss) income allocable to Class A common stock subject to possible redemption
   $ (5,571,661   $ (153,400   $ (2,167,037   $ 7,243,954  
Denominator:
        
Weighted Average Redeemable Class A common stock, Basic and Diluted
     8,169,859       28,750,000       12,660,640       28,750,000  
  
 
 
   
 
 
   
 
 
   
 
 
 
Basic and Diluted net (loss) income per share, Redeemable Class A common stock
   $ (0.68   $ (0.01   $ (0.17   $ 0.25  
  
 
 
   
 
 
   
 
 
   
 
 
 
Non-Redeemable
common stock
        
Numerator:
        
Net (loss) income allocable to Class A and Class B common stock not subject to redemption
   $ (4,901,714   $ (38,350   $ (1,230,237   $ 1,810,988  
Denominator:
        
Weighted Average
Non-redeemable
Class A and Class B common stock, Basic and Diluted
     7,187,500       7,187,500       7,187,500       7,187,500  
  
 
 
   
 
 
   
 
 
   
 
 
 
Basic and diluted net (loss) income per share of
Non-redeemable
Class A and Class B common stock
   $ (0.68   $ (0.01   $ (0.17   $ 0.25  
  
 
 
   
 
 
   
 
 
   
 
 
 
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the condensed balance sheets.
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period.
The Company accounts for its 22,125,000 common stock warrants issued in connection with its Initial Public Offering (14,375,000) and Private Placement (7,750,000) as derivative warrant liabilities in accordance with ASC
815-40.
Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed
statements of operations. The fair value of warrants issued by the Company in connection with the Initial Public Offering and Private Placement had been estimated using Monte-Carlo simulations at the initial measurement date. However, for each subsequent measurement, beginning on April 19, 2021, the public warrants were measured at the Observable Quoted Price in Active Markets and the private warrants were measured using the Modified Black-Scholes Option Pricing Model.
Convertible Promissory Notes—Related Party
The Company accounts for the convertible promissory notes under ASC 815. The Company has made the election under
815-15-25
to account for the notes under the fair value option. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Differences between the face value of the note and fair value at issuance are recognized as either an expense in the condensed statement of operations (if issued at a premium) or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as
non-cash
gains or losses in the condensed statements of operations.  
Income Taxes
The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC 740 also requires that an annual effective tax rate be determined and that such annual effective rate be applied to
year-to-date
income in interim periods. Using provisions of ASC 740 that allow certain tax items to be recorded in the interim period in which these items are reported, the Company’s effective tax rate was negative 1.42% and 156.66% for the three months ended September 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three months ended September 30, 2023 and 2022, due primarily to changes in fair value of the warrant liability, which are not included in taxable income, non-deductible merger related expenditures, and the valuation allowance on the deferred tax assets.
The Company’s effective tax rate was negative 30.08% and 5.53% for the nine months ended September 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the nine months ended September 30, 2023 and 2022, due primarily to changes in fair value of the warrant liability, which are not included in taxable income, non-deductible merger related expenditures, and the valuation allowance on the deferred tax assets.
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position
taken
or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
 
The Company has identified the United States as its only “major” tax jurisdiction.
The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Standards
In August 2020, the FASB issued ASU
2020-06,
“Debt-Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic
815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU
2020-06”),
which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for scope exception, and it simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06
is effective no later than January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently reviewing what impact, if any, adoption will have on the Company’s financial position, results of operations or cash flows.
The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.
NOTE 2— SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for annual financial information and in accordance with the instructions to Form
10-K and
Article 8 of
Regulation S-X of
the U.S. Securities and Exchange Commission (“SEC”).
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies, but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences
in
accounting standards used.
Use of Estimates
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and 2021.
Marketable Securities Held in Trust Account
At December 31, 2022 and 2021, the Trust Account had $290,718,297 and $287,516,153 held in marketable securities, respectively. During the period ended December 31, 2022, the Company withdrew $786,918 of interest income from the Trust Account to pay its tax obligations. During the period ended December 31, 2021, the Company did not withdraw any interest income from the Trust Account to pay its tax obligations.
 
Marketable securities held in the Trust Account are classified as “Trading Securities” in accordance with ASC 320, “Investments – Debt Securities” and are reported at fair value with unrealized gains or losses included in earnings of the current period.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At December 31, 2022 and 2021, the Company did not experience losses on this account.
Class A Common Stock Subject to Possible Redemption
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity (deficit).
 
The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 
31
,
2022
and
2021
,
28,750,000
shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.
Under ASC
480-10-S99,
the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of our initial public offering, we recognized the accretion from initial book value to redemption amount, which, resulted in charges against additional
paid-in
capital (to the extent available) and accumulated deficit.
The amount accreted in 2022 represents investment income accrued in the Trust Account since the date of the IPO reduced by the amounts of Delaware franchise tax and income taxes paid and payable for 2021 and 2022, net of cash withdrawn from the Trust Account to pay these
obligations.

At December 31, 2022 and 2021, the Class A common stock reflected in the balance sheets is reconciled in the following table:
 
Gross proceeds from Initial Public Offering
   $ 287,500,000  
Less:
        
Common stock issuance costs
     (6,326,922
Proceeds allocated to public warrants
     (12,218,750
Plus:
        
Remeasurement of Class A common stock to possible redemption
     18,545,672  
    
 
 
 
Contingently redeemable common stock at December 31, 2021
  
 
287,500,000
 
    
 
 
 
Plus:
        
Remeasurement of Class A common stock to possible redemption
     2,847,008  
    
 
 
 
Contingently redeemable common stock at December 31, 2022
  
$
290,347,008
 
    
 
 
 
 
On February 23, 2023
, in connection with the Extension described in Note 11
,
the
Company was notified by stockholders holding 20,317,255 shares of Class A Common Stock that they exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $206,121,060 (approximately $10.15 per share) was removed from the Trust Account to pay such redeeming holders on March 2, 2023.
Net (Loss) Income Per Share of Common Stock
The Company complies with accounting and disclosure requirements of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260, “Earnings Per Share.” Net (loss) income per share of common stock is computed by dividing net income by the weighted average number of shares of common stock outstanding for the period. Subsequent remeasurement of the redeemable Class A common stock is excluded from income per share of common stock as the redemption value approximates fair value. Net (loss) income per share of common stock is computed by dividing the pro rata net (loss) income between the shares of Class A common stock and the shares of Class B common stock by the weighted average number of shares of common stock outstanding for each of the periods. The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the IPO, as well as warrants issuable upon the exercise of the conversion option on outstanding working capital loans, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for
23,625,000
and 23,290,000
shares of Class A common stock in the aggregate
 as of December 31, 2022 and 2021, respectively
.
The following table reflects the calculation of basic and diluted net (loss) income per share of common stock (in dollars, except share amounts):
 
 
  
For the Years Ended
December 31,
 
 
  
2022
 
  
2021
 
Common stock subject to possible redemption
                 
Numerator:
                 
Net (loss) income allocable to Class A common stock subject to possible redemption
   $ (2,072,758    $ 3,301,319  
Denominator:
                 
Weighted Average Redeemable Class A common stock, Basic and Diluted
     28,750,000        24,417,808  
Basic and Diluted net (loss) income per share, Redeemable Class A common stock
   $ (0.07    $ 0.14  
Non-Redeemable
Ordinary shares
                 
Numerator:
                 
Net (loss) income allocable to Class B common stock not subject to redemption
   $ (518,190    $ 971,759  
Denominator:
                 
Weighted
Average Non-Redeemable common
stock, Basic and Diluted
     7,187,500        7,187,500  
Basic and diluted net (loss) income per share
   $ (0.07    $ 0.14  
Offering Costs
The Company complies with the requirements of ASC
340-10-S99-1
and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering and that were allocated among common stock subject to possible redemption and to stockholders’ deficit upon the completion of the IPO. Accordingly, during the period ended December 31,
2021
, offering
costs
totaling $6,607,751 were charged to
 
temporary equity and stockholders’ deficit (consisting of $5,750,000 of underwriting fee and $857,751 of other offering costs). Of the total transaction cost, $280,829 was allocated to warrants as a
non-operating
expense in the statement of operations for the
year
 ended December 31, 2021, with the rest of the offering costs allocated among common stock subject to possible redemption and to stockholders’ deficit. The transaction costs were allocated based on the with and without method, compared to the total offering proceeds, between the fair value of the public warrant liabilities and the Class A common stock.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value
Measurement”
approximates the carrying amounts represented in the balance sheets.
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period.
The Company accounts for its 22,125,000 common stock warrants issued in connection with its Initial Public Offering (14,375,000) and Private Placement (7,750,000) as derivative warrant liabilities in accordance with ASC
815-40.
Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of warrants issued by the Company in connection with the Initial Public Offering and Private Placement had been estimated using Monte-Carlo simulations at the initial measurement date. However, for each subsequent measurement, beginning on April 19, 2021, the public warrants were measured at the Observable Quoted Price in Active Markets and the private warrants were measured using the Modified Black-Scholes Option Pricing Model.
Convertible Promissory Notes—Related Party
The Company accounts for the convertible promissory notes under ASC 815. The Company has made the election under ASC
815-15-25
to account for the notes under the fair value option. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Differences between the face value of the note and fair value at issuance are recognized as either an expense in the statement of operations (if issued at a premium) or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as
non-cash
gains or losses in the statements of operations.
Income Taxes
The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
 
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in annual period, disclosure and transition.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were
no
unrecognized tax benefits and
no
amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company has identified the United States as its only “major” tax jurisdiction.
The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Standards
In August 2020, the FASB issued
ASU 2020-06, “Debt-Debt
with Conversion and Other Options
(Subtopic 470-20)
and Derivatives and Hedging-Contracts in Entity’s Own Equity
(Subtopic 815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”
(“ASU 2020-06”),
which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for scope exception, and it simplifies the diluted earnings per share calculation in certain areas.
ASU 2020-06
is effective no later than January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently reviewing what impact, if any, adoption will have on the Company’s financial position, results of operations or cash flows.
The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.
v3.24.0.1
Initial Public Offering
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Equity [Abstract]    
Initial Public Offering
Note 3 — Initial Public Offering
Pursuant to the Initial Public Offering, the Company sold 28,750,000 Units, which includes the full exercise by the underwriters of their option to purchase an additional 3,750,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock, par value $0.0001 per share, and
one
-half
of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share.
NOTE 3 — INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company sold 28,750,000 Units, which includes the full exercise by the underwriters of their option to purchase an additional 3,750,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of Class A Common Stock, par value $0.0001 per share, and
one
-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A Common Stock at a price of $11.50 per share.
v3.24.0.1
Private Placement Warrants
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Warrants and Rights Note Disclosure [Abstract]    
Private Placement Warrants
Note 4 — Private Placement Warrants
Simultaneously with the closing of the IPO, the Sponsor, Intrepid Financial Partners, LLC (an affiliate of one of the Company’s underwriters) (“Intrepid Financial Partners”) and FL
Co-Investment,
LLC (an affiliate of one of the Company’s underwriters) (“FL
Co-Investment”)
collectively, the (“Initial Stockholders”), purchased an aggregate of 7,750,000 Private Placement Warrants at a price of $1.00 per warrant ($7,750,000 in the aggregate), and each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from this offering to be held in the Trust Account.
NOTE 4 — PRIVATE PLACEMENT WARRANTS
Simultaneously with the closing of the IPO, the Sponsor, Intrepid Financial Partners, LLC (an affiliate of one of the Company’s underwriters) (“Intrepid”) and FL
Co-Investment,
LLC (an affiliate of one of the Company’s underwriters) (“FL
Co-Investment”)
collectively, the (“Initial Stockholders”), purchased an aggregate of 7,750,000 Private Placement Warrants at a price of $1.00 per warrant ($7,750,000 in the aggregate), and each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from this offering to be held in the Trust Account. Proceeds in excess of the initial fair value of Private Placement Warrants of $1,166,375 are included
in
the
statement of changes in stockholders’ equity (deficit) for the year ended December 31, 2021.
v3.24.0.1
Related Party Transactions
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Related Party Transactions [Abstract]    
Related Party Transactions
Note 5 — Related Party Transactions
Founder Shares
In November 2020, our founders acquired 7,187,500 founder shares (the “Founder Shares”) for an aggregate purchase price of $25,000 (the “Class B common stock”), or approximately $0.0035 per share. The Sponsor purchased 4,671,875 Founder Shares, FL
Co-Investment
purchased 1,257,813 Founder Shares and Intrepid Financial Partners purchased 1,257,812 Founder Shares. On November 25, 2020, the Sponsor sold 434,375 Founder Shares to some of the Company’s directors and executives, including Gregory D. Patrinely, the Company’s Chief Financial Officer and Secretary, at their original purchase price. Simultaneously with such transfer, each of FL
Co-Investment
and Intrepid Financial Partners transferred 13,125 Founder Shares to the
Sponsor, respectively, at their original purchase price. Such sale of Founder Shares to the Company’s directors and executives is within the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Founder Shares were sold to directors and executives and effectively transferred subject to a performance condition (i.e., the consummation of a Business Combination). Compensation expense related to the Founder Shares is recognized only when the performance condition is probable of achievement under the applicable accounting literature. Stock-based compensation would be recognized at the date a Business Combination is considered probable in an amount equal to the number of Founder Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founder Shares. On November 2, 2022, the Company entered into the Merger Agreement (see Note 1); however, the Merger Agreement is subject to certain conditions to closing, such as, for example, approval by the Company’s stockholders. As a result, the Company determined that there is a possibility that a Business Combination might not happen and, therefore, no stock-based compensation expense has been recognized.
The Initial Stockholders have agreed that, subject to certain limited exceptions, the Founder Shares will not be transferred, assigned, sold or released from escrow until the earlier of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, if (x) the last reported sale price of the shares of our Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after a Business Combination, or (y) the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property, the converted Class A common stock will be released from the
lock-up.
On August 22, 2023, we issued an aggregate of 7,187,500 shares of Class A common stock to the Sponsor, FL
Co-Investment,
Intrepid Financial Partners, our independent directors and certain of our executive officers, upon the conversion of an equal number of shares of Class B common stock (the “Class B Conversion”). The 7,187,500 shares of Class A common stock issued in connection with the Class B Conversion are subject to the same restrictions as applied to the shares of Class B common stock before the Class B Conversion, including, among other things, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination, as described in the prospectus for the Initial Public Offering (“IPO”) . After the Class B Conversion, no shares of Class B common stock remained outstanding.
Convertible Promissory Notes (“Working Capital Loans”)
In order to finance transaction costs in connection with a Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain of the Company’s directors and officers may, but are not obligated
to
, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company or convert them to warrants as described below. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. Initially up to $1,500,000, which was increased to $3,500,000 on March 24, 2023, of such loans may be convertible into warrants. The warrants would be identical to the Private Placement Warrants. As discussed below, since inception, the Company has entered into nine convertible promissory notes under this arrangement with the Sponsor to provide Working
Capital
Loans.
 
On March 1, 2021, the Company issued an unsecured promissory note to the Sponsor (the “First Working Capital Loan”), pursuant to which the Company may borrow up to an aggregate principal amount of $365,000. The First Working Capital Loan is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. The First Working Capital Loan was fully drawn down in the period ended December 31, 2021. The Sponsor assigned $145,000 of the First Working Capital Loan to our Executive Vice President and Chief Financial Officer, Gregory Patrinely, $110,000 of the First Working Capital Loan to our Executive Vice President, General Counsel and Secretary, Anthony Duenner, and $110,000
of the First Working Capital Loan to our President, J. Caldwell Flores. As of September 30, 2023 and December 31, 2022, the First Working Capital Loan in the amount of
$365,000 was fully drawn. The fair value of the note was estimated by the Company to be $383,323 at initial measurement, $292,000 and $343,034 at September 30, 2023 and December 31, 2022, respectively.
On December 27, 2021, the Company issued an unsecured promissory note to the Sponsor (the “Second Working Capital Loan”), pursuant to which the Company may borrow up to an aggregate principal amount of
$800,000. The Second Working Capital Loan is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. As of September 30, 2023 and December 31, 2022, the Second Working Capital Loan in the amount of $800,000 was fully drawn. The fair value of the note was estimated by the Company to be $656,560 at initial measurement, $640,000 and $751,856 at September 30, 2023 and December 31, 2022, respectively.
On March 29, 2022, the Company issued an unsecured promissory note to the Sponsor (the “Third Working Capital Loan”), pursuant to which the Company may borrow up to an aggregate principal amount of $335,000. The Third Working Capital Loan is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. As of September 30, 2023 and December 31, 2022, the Third Working Capital Loan in the amount of $335,000 was fully drawn. The Sponsor assigned $111,667
of the Third Working Capital Loan to each of our Executive Vice President and Chief Financial Officer, Gregory Patrinely, and President J. Caldwell Flores, and
$111,666 of the Third Working Capital Loan to our Executive Vice President, General Counsel and Secretary, Anthony Duenner. The fair value of the note was estimated by the Company to be $282,874 at initial measurement, and the amount by which the proceeds from the Third Working Capital Loan exceeded its initial fair value has been recognized as a credit within stockholders’ deficit during the year ended December 31, 2022. The fair value of the note was estimated by the Company to be $268,000 and $314,840 at September 30, 2023 and December 31, 2022, respectively.
On September 30, 2022, the Company issued an unsecured promissory note to the Sponsor (the “Q3 2022 Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $170,000 (see Promissory Note Amendments above). The Q3 2022 Promissory Note is non-interest bearing and payable on the consummation of the Company’s Business Combination. On October 5, 2022, the Q3 2022 Promissory Note was fully drawn down by the Company. The fair value of the note was estimated by the Company to be $136,000 at September 30, 2023.
On October 31, 2022, the Company issued an unsecured promissory note to the Sponsor (the “Q4 2022 Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $200,000 (see Promissory Note Amendments above). The Q4 2022 Promissory Note is non-interest bearing and payable on the consummation of the Company’s Business Combination. On October 31, 2022, the Q4 2022 Promissory Note was fully drawn down by the Company. The fair value of the note was estimated by the Company to be $160,000 at September 30, 2023.
On February 6, 2023, the Company issued an unsecured promissory note to the Sponsor (the “Q1 2023 Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $535,000 of which $356,370 is convertible in to warrants post-Business Combination (see Promissory Note Amendments below). The Q1 2023 Promissory Note is non-interest bearing and payable on the consummation of the Company’s Business Combination. On February 7, 2023, the Q1 2023
Promissory
Note
was
fully drawn
down by the Company. The fair value of the convertible portion of the note was estimated by the Company to be $285,096 at September 30, 2023.
On May 12, 2023, the Company issued an unsecured promissory note to the Sponsor (the “First Q2 2023 Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $395,000. The First Q2 2023 Promissory Note is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. On May 15, 2023, the First Q2 2023 Promissory Note was fully drawn down by the Company. The fair value of the note was estimated by the Company to be $229,653 at initial measurement, and the amount by which the proceeds from the First Q2 2023 Promissory Note exceeded its initial fair value has been recognized as a credit within stockholders’ deficit during the nine months ended September 30, 2023. The fair value of the note was estimated by the Company to be $316,000 at September 30, 2023.
On June 22, 2023, the Company issued an unsecured promissory note to the Sponsor (the “Fourth Q2 2023 Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $50,000. The Fourth Q2 2023 Promissory Note is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. The fair value of the note was estimated by the Company to be $29,150 at initial measurement and $40,000 at September 30, 2023, and the amount by which the proceeds from the Fourth Q2 2023 Promissory Note exceeded its initial fair value has been recognized as a credit within stockholders’ deficit during the nine months ended September 30, 2023. On June 28, 2023, the Fourth Q2 2023 Promissory Note was fully drawn down by the Company.
On August 30, 2023, the Company issued an unsecured promissory note to the Sponsor (the “First Q3 2023 Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $
635,000
.
The First Q3 2023 Promissory Note is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. The fair value of the note was estimated by the Company to be $
330,199
at initial measurement and $
508,000
at September 30, 2023, and the amount by which the proceeds from the First Q3 2023 Promissory Note exceeded its initial fair value has been recognized as a credit within stockholders’ deficit during the three and nine months ended September 30, 2023. On August 30, 2023, the First Q3 2023 Promissory Note was fully drawn down by the Company.
On March 29, 2023, the Company and Flame Acquisition Sponsor LLC entered into amendments to each of the Q3 2022 Promissory Note, Q4 2022 Promissory Note and Q1 2023 Promissory Note, pursuant to which loans made under such notes are, at the lender’s discretion, convertible into warrants of the post-Business Combination entity. On May 12, 2023, the Q1 2023 Promissory note was amended to clarify that approximately $
356,370 of the note proceeds are convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant, while the remainder of the note proceeds are
non-convertible
notes to be used to fund advances to the acquisition target. Such warrants are identical to the private placement warrants, including as to exercise price, exercisability and exercise period. The Company evaluated the amendments to each of the Q3 2022 Promissory Note, Q4 2022 Promissory Note and Q1 2023 Promissory Note under ASC
470-50,
“Debt – Modification and Extinguishment”, and concluded that the amendments resulted in terms that were substantially different and thus resulted in debt extinguishments. The fair value of the Q3 2022 Promissory Note, Q4 2022 Promissory Note and Q1 2023 Promissory Note ($726,370 in aggregate proceeds) was estimated by the Company to be $684,165 upon the amendments. The amount by which the proceeds from each of the Q3 2022 Promissory Note, Q4 2022 Promissory Note and Q1 2023 Promissory Note exceeded their fair value has been recognized as a capital contribution within stockholders’ deficit during the nine months ended September 30, 2023.
As of
September 30, 2023
, each of the First Working Capital Loan, Second Working Capital Loan, Third Working Capital Loan, Q
3
2022
Promissory Note, Q
4
2022
Promissory Note, First Q
2
2023
Promissory Note, Fourth Q
2
2023
Promissory Note, First Q
3
2023
Promissory Note and a portion of the Q
1
2023
Promissory Note may be convertible into warrants ($
3,306,370
in total proceeds or
3,306,370
in aggregate warrants as of
September 30, 2023
) at a price of $
1.00
per warrant at the option of the lender. There were
no
additional borrowings under Convertible Promissory Notes other than those described above.
 
Promissory Note Loans
In addition, the Company has borrowed certain funds from
the
Sponsor under
non-convertible
promissory notes (“Promissory Note Loans”) that have been used to pay for expenditures of the acquisition target. As discussed below, since inception, the Company has entered into four
non-convertible
promissory notes under this arrangement with the Sponsor. In accordance with the Merger Agreement, the Company is to pay for up to $1.5 million (subsequently amended to a cap of $3.0 million) in reasonable
out-of-pocket
fees and expenses for any agents, advisors, consultants, experts, independent contractors and financial advisors engaged on behalf of Holdco or Sable and incurred in connection with the transactions contemplated by the Merger Agreement and
Sable-EM
Purchase Agreement at closing of the Business Combination. During the three and nine months ended September 30, 2023, the Company paid $123,897 and $726,868, respectively, in such expenditures on behalf of Sable which have been recorded and included in Operating costs on the condensed statements of operations for the three and nine months ended September 30, 202
3. From October 1, 2023 to November 14, 2023, the Company paid approximately $106,000 in additional such expenditures on behalf of Sable. T
he Company is under no obligation to make further advances prior to the closing of the Business Combination.

On May 12, 2023, the Company issued an unsecured promissory note to the Sponsor (the “Second Q2 2023 Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $355,000. The Second Q2 2023 Promissory Note is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. On May 15, 2023, the Second Q2 2023 Promissory Note was fully drawn down by the Company.
On June 22, 2023, the Company issued an unsecured promissory note to the Sponsor (the “Third Q2 2023 Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $100,000. The Third Q2 2023 Promissory Note is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. On June 28, 2023, the Third Q2 2023 Promissory Note was fully drawn down by the Company.
On August 30, 2023, the Company issued an unsecured promissory note to the Sponsor (the “Second Q3 2023 Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $
495,000.
The Second Q3 2023 Promissory Note is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. On August 30, 2023, the Second Q3 2023 Promissory Note was fully drawn down by the Company.
As of September 30, 2023, each of the First Working Capital Loan, Second Working Capital Loan, Third Working Capital Loan, Q3 2022 Promissory Note, Q4 2022 Promissory Note, First Q2 2023 Promissory Note, Fourth Q2 2023 Promissory Note, First Q3 2023 Promissory Note and a portion of the Q1 2023 Promissory Note (collectively the “Convertible Promissory Notes”) may be convertible into warrants ($
3,306,370 in total proceeds or 3,306,370 in aggregate warrants as of September 30, 2023) at a price of $1.00 per warrant at the option of the lender. There were no additional borrowings under Convertible Promissory Notes other than those described above.
 
The following tables presents the balances of the convertible promissory notes – related parties, at fair value and the promissory notes to related parties as of the respective period ends:

 
 
Principal Value
 
 
Fair Value
 
 
 
$ Amount
 
 
September 30, 2023
 
 
December 31, 2022
 
Convertible notes –related parties, at fair value
                          
First Working Capital Loan
   $ 365,000      $ 292,000      $ 343,034  
Second Working Capital Loan
     800,000        640,000        751,856  
Third Working Capital Loan
     335,000        268,000        314,840  
Q3 2022 Promissory Note
     170,000        136,000         
Q4 2022 Promissory Note
     200,000        160,000         
Q1 2023 Promissory Note
     356,370        285,096         
First Q2 2023 Promissory Note
     395,000        316,000         
Fourth Q2 2023 Promissory Note
     50,000        40,000         
First Q3 2023 Promissory Note
     635,000        508,000         
    
 
 
    
 
 
    
 
 
 
Total
  
$
3,306,370
 
  
$
2,645,096
 
  
$
1,409,730
 
Promissory notes to related parties
                          
Q3 2022 Promissory Note
  
$
     $      $ 170,000  
Q4 2022 Promissory Note
                   200,000  
Q1 2023 Promissory Note
     178,630        178,630         
Second Q2 2023 Promissory Note
     355,000        355,000         
Third Q2 2023 Promissory Note
     100,000        100,000         
Second Q3 2023 Promissory Note
     495,000        495,000         
    
 
 
    
 
 
    
 
 
 
Total
  
$
1,128,630
 
  
$
1,128,630
 
  
$
370,000
 
NOTE 5 — RELATED PARTY TRANSACTIONS
Founder Shares
In November 2020, our founders acquired 7,187,500 founder shares (the “Founder Shares”)
for
an aggregate purchase price of $25,000 (the “Class B common stock”), or approximately $0.0035 per share. The Sponsor purchased 4,671,875 Founder Shares, FL
Co-Investment
purchased 1,257,813 Founder Shares and Intrepid Financial Partners purchased 1,257,812 Founder Shares. On November 25, 2020, the Sponsor sold 434,375
Founder Shares to some of the Company’s directors and executives, including Gregory D. Patrinely, the Company’s Chief Financial Officer and Secretary, at their original purchase price. Simultaneously with such transfer, each of FL Co-Investment and Intrepid Financial Partners transferred 13,125 Founder Shares to the Sponsor, respectively, at their original purchase price. Such sale of Founder Shares to the Company’s directors and executives is within the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Founder Shares were sold to directors and executives and effectively transferred subject to a performance condition (i.e., the consummation of a Business Combination). Compensation expense related to the Founder Shares is recognized only when the performance condition is probable of achievement under the applicable accounting literature. Stock-based compensation would be recognized at the date a Business Combination is considered probable in an amount equal to the number of Founder Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founder Shares. On November 2, 2022, the Company entered into the Merger Agreement (see Note 1); however, the Merger Agreement is subject to certain conditions to closing, such as, for example, approval by the Company’s stockholders. As a result, the Company determined that there is a possibility that a Business Combination might not happen and, therefore, no stock-based compensation expense has been recognized. 

The Initial Stockholders have agreed that, subject to certain limited exceptions, the Founder Shares will not be transferred, assigned, sold or released from escrow until the earlier of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, if (x) the last reported sale price of the shares of our Class A common stock equals or exceeds $
12.00
 per share (as adjusted for stock splits, stock, reorganizations, recapitalizations and the like) 
for any 20 trading days within any
30-trading
day period commencing at least 150 days after a Business Combination, or (y) the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property, the converted Class A common stock will be released from the
lock-up.
Initial Promissory Note
On November 25, 2020, the Company issued an unsecured promissory note to the Initial Stockholders (the “Initial Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $
300,000
. The Initial Promissory Note was
non-interest
bearing and payable on the earlier of (i) 
May 25, 2021
or (i) the consummation of the IPO. The Company borrowed $
75,000
under the Initial Promissory Note and repaid the Initial Promissory Note in full as of June 30, 2021.
No
additional borrowings under such the Initial Promissory Note are available.
Working Capital Loans
In order to finance transaction costs in connection with a Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company, or convert them to warrants as described below. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to rep
ay
 
the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. Initially up to $1,500,000, which was increased to $3,500,000
on March 24, 2023, of such loans may be convertible into warrants. The warrants would be identical to the Private Placement Warrants. As discussed below, since inception, the Company has entered into six convertible promissory notes under this arrangement with the Sponsor to provide Working Capital Loans.
Convertible Promissory Notes
On March 1, 2021, the Company issued an unsecured promissory note to the Sponsor (the “First Working Capital Loan”), pursuant to which the Company may borrow up to an aggregate principal amount of $365,000. The First Working Capital Loan is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. The First Working Capital Loan was fully drawn down in the period ended December 31, 2021. The Sponsor assigned $145,000 of the First Working Capital Loan to our
Executive Vice President and
Chief Financial Officer, Gregory Patrinely, $110,000 of the First Working Capital Loan to our
Executive
Vice President,
General Counsel and Secretary,
Anthony Duenner, and $110,000
of the First Working Capital Loan to our President, J. Caldwell Flores. As of December 31, 2022 and 2021, the First Working Capital Loan in the amount of
$365,000 was fully drawn. The fair value of the note was estimated by the Company to be $383,323 at initial measurement and $343,034 and $299,555 at December 31, 2022 and 2021, respectively.
On December 27, 2021, the Company issued an unsecured promissory note to the Sponsor (the “Second Working Capital Loan”), pursuant to which the Company may borrow up to an aggregate principal amount of $
800,000
. The Second Working Capital Loan is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. As of December 31, 2022 and 2021, the Second Working Capital Loan in the amount of $
800,000
was fully drawn. The fair value of the note was estimated by the Company to be $
656,560
at initial measurement and at December 31, 2021. The fair value of the note was estimated by the Company to be $
751,856
at December 31, 2022.
On March 29, 2022, the Company issued an unsecured promissory note to the Sponsor (the “Third Working Capital Loan”), pursuant to which the Company may borrow up to an aggregate principal amount of $335,000. The Third Working Capital Loan is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. As of December 31, 2022, the Third Working Capital Loan in the amount of $335,000 was fully drawn. The fair value of the note was estimated by the Company to be $282,874 at initial measurement and at March 31, 2022, and the amount by which the proceeds from the Third Working Capital Loan exceed
ed
its initial fair value has been recognized as a credit within stockholders’ deficit during the year ended December 31, 2022. The fair value of the note was estimated by the Company to be $314,840 at December 31, 2022.
As of December 31, 2022, there were no additional borrowings under Working Capital Loans other than the $365,000 outstanding under the First Working
Capital
Loan, $800,000 outstanding under the Second Working Capital Loan and $335,000 outstanding under the Third Working Capital Loan, as described above.
Q3 2022 Promissory Note
On September 30, 2022, the Company issued an unsecured promissory note to the Sponsor (the “Q3 2022 Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $170,000
. The Q3 2022 Promissory Note is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. On October 5, 2022, the Q3 2022 Promissory Note was fully drawn down by the Company.
 
Q4 2022 Promissory Note
On October 31, 2022, the Company issued an unsecured promissory note to the Sponsor (the “Q4 2022 Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $200,000
. The Q4 2022 Promissory Note is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. On October 31, 2022, the Q4 2022 Promissory Note was fully drawn down by the Company.
See Note 11 for discussion of the Q1 2023 Promissory Note and amendments to the Q3 2022 Promissory Note, Q4 2022 Promissory Note and Q1 2023 Promissory Note.
v3.24.0.1
Commitments And Contingencies
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]    
Commitments And Contingencies
Note 6 — Commitments and Contingencies
Registration
Rights
The holders of the Founder
Shares
, Private Placement Warrants and warrants that may be issued upon conversion
of
the Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement. The holders of these securities, and certain Promissory Notes, are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Business Combination Marketing Agreement
The Company has engaged underwriters as advisors in connection with its business combination to assist it in holding meetings with the Company’s stockholders to discuss the potential business combination and the target business’s attributes, introduce it to potential investors that are interested in purchasing its securities in connection with the potential business combination, assist it in obtaining stockholder approval for the business combination and assist the Company with its press releases and public filings in connection with the business combination. The Company will pay the Marketing Fee (as defined in the Company’s registration statement on Form
S-1,
as amended, that was filed with the SEC on February 5, 2021) for such services upon the consummation of its initial business combination in an amount equal to, in the aggregate, 3.5% of the gross proceeds of the IPO, including the proceeds from the exercise of the
over
-allotment option. The underwriters will
 
not be entitled to such fee unless the Company consummates its initial business combination. In connection with the Extension, stockholders holding 20,317,255 shares of Flame Class A common stock subject to possible redemption stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account, representing approximately 70.67% of our issued and outstanding Flame Class A common stock subject to possible redemption stock. After this redemption, 8,432,745 shares of Flame Class A common stock subject to possible redemption stock remained outstanding. In connection with the Second Extension, stockholders holding 2,328,063 shares of Flame Class A common stock subject to possible redemption stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account, representing approximately 27.61% of our issued and outstanding Flame Class A common stock subject to possible redemption stock. After this redemption, 6,104,682 shares of Flame Class A common stock subject to possible redemption stock remained outstanding. If no additional public stockholders exercise redemption rights with respect to their shares of Flame Class A common stock, the amount of effective underwriting commissions due to the underwriters upon the consummation of the Business Combination will represent 15.9% of the aggregate proceeds from the Flame IPO retained by Flame.
Underwriters Agreement
On March 1, 2021, the Company paid a fixed underwriting discount of $0.20 per Unit, or $5,750,000 in the aggregate.
Deferred Legal Fees
As of September 30, 2023 and December 31, 2022, the Company has incurred unbilled legal costs of $3,623,594 and $2,633,139, respectively, related to its prospective initial Business Combination. These costs are deferred until the completion of the Company’s initial Business Combination and are included in accounts payable and accrued expenses on the Company’s condensed balance sheets.
NOTE 6 — COMMITMENTS 
AND
 CONTINGENCIES
Registration Rights
The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Business Combination Marketing Agreement
The Company has engaged underwriters as advisors in connection with its business combination to assist it in holding meetings with the Company’s stockholders to discuss the potential business combination and the target business’s attributes, introduce it to potential investors that are interested in purchasing its securities in connection with the potential business combination, assist it in obtaining stockholder approval for the business combination and assist the Company with its press releases and public filings in connection with the business combination. The Company will pay the Marketing Fee (as defined in the Company’s registration statement on Form
S-1,
as amended, that was filed with the SEC on February 5, 2021) for such services upon the consummation of its initial business combination in an amount equal to, in the aggregate, 3.5% of the gross proceeds of the IPO, including the proceeds from the exercise of the over-allotment option. The underwriters will not be entitled to such fee unless the Company consummates its initial business combination.
Underwriters Agreement
On March 1, 2021, the Company paid a fixed underwriting discount of $0.20 per Unit, or $5,750,000 in the aggregate.
Deferred Legal Fees
As of December 31, 2022, the Company has incurred unbilled legal costs of $2,633,139
 
related to its prospective initial Business
Combination. These costs are deferred until the completion of the Company’s initial Business Combination and are included in accounts payable and accrued expenses on the Company’s balance sheets. There were no deferred legal costs as of December 31, 2021.
v3.24.0.1
Stockholders' Deficit
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Stockholders' Equity Note [Abstract]    
Stockholders' Deficit
Note 7 — Stockholders’ Deficit
Preferred Stock
— The Company is authorized to issue a total of 1,000,000 shares of preferred stock at par value of $0.0001 each. At September 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding.
Class
 A Common Stock
— The Company is authorized to issue a total of 200,000,000 shares of Class A common stock at par value of $0.0001 each. At September 30, 2023 and December 31, 2022, there were 7,187,500 and no shares, respectively, issued and outstanding (excluding 6,104,682 and 28,750,000 shares subject to possible redemption, respectively). On February 23, 2023, the Company was notified by stockholders holding 20,317,255 shares of Class A common stock that they exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $206,121,060 (approximately $10.15 per share) was removed from the Trust Account to pay such redeeming holders on March 2, 2023. On August 29, 2023, the Company was notified by stockholders holding 2,328,063 shares of Class A common stock that they exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $24,008,096 (approximately $10.31 per share) was removed from the Trust Account to pay such redeeming holders on August 31, 2023.
On August 22, 2023, we issued an aggregate of 7,187,500 shares of Class A common stock to the Sponsor, FL
Co-Investment,
Intrepid Financial Partners, our independent directors and certain of our executive officers, upon the Class B Conversion transaction. After the Class B Conversion, no shares of Class B common stock remained outstanding.
Class
 B Common Stock
— The Company is authorized to issue a total of 20,000,000 shares of Class B common stock at par value of $0.0001 each. At September 30, 2023 and December 31, 2022, there were 0 and 7,187,500 shares of Class B common stock, respectively, issued or outstanding.
 
Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of the Class A common stock and holders of the Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders, except as required by law.
Shares of the Class B common stock are identical to the shares of Class A common stock included in the units sold in the IPO, and holders of Class B common stock have the same stockholder rights as public stockholders, except that (i) the Class B common stock are subject to certain transfer restrictions, as described in more detail below, (ii) our founders, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed (A) to waive their redemption rights with respect to any Class B common stock and any Public Shares held by them in connection with the completion of our Business Combination and (B) to waive their rights to liquidating distributions from the Trust Account with respect to any Class B common stock held by them if the Company fails to complete our Business Combination within the prescribed time period, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete our Business Combination within such time period, (iii) the Class B common stock are shares of our Class B common stock that will automatically convert into shares of our Class A common stock at the time of our initial Business Combination, on a
one-for-one
basis, subject to adjustment pursuant to certain anti-dilution rights and (iv) are subject to registration rights. If the Company submits our Business Combination to our public stockholders for a vote, our Initial stockholders have agreed to vote any Class B common stock and any Public Shares purchased during or after the IPO in favor of our initial Business Combination.
With certain limited exceptions, the Class B common stock are not transferable, assignable or salable (except to our officers and directors and other persons or entities affiliated with the Sponsor, each of whom will be subject to the same transfer restrictions) until the earlier of (A) one year after the completion of our initial Business Combination or (B) subsequent to our initial Business Combination, (x) if the last sale price of our Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after our initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property.
The 7,187,500 shares of Class A common stock issued in connection with the Class B Conversion are subject to the same restrictions as applied to the shares of Class B common stock before the Class B Conversion, including, among other things, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination, as described in the prospectus for the IPO described above.
NOTE 7 — STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred Stock
— The Company is
 authorized to issue a total of
1,000,000
shares of preferred stock at par value of $
0.0001
each. At December 31, 2022 and 2021, there were
no
shares of preferred stock issued or outstanding
.
 
Class
 A Common Stock
— The Company is
 authorized to issue a total of
200,000,000
shares of Class A common stock at par value of $
0.0001
each. At December 31, 2022 and 2021, there were
no
shares issued and outstanding (excluding
28,750,000
shares subject to possible redemption
)
Class
 B Common Stock
— The Company is
 authorized to issue a total of
20,000,000
shares of Class B common stock at par value of $
0.0001
each. At December 31, 2022 and 2021, there were
7,187,500
 shares of Class B common stock issued or outstanding
.
Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of the Class A common stock and holders of the Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders, except as required by law.
The Class B common stock are identical to the shares of Class A common stock included in the units being sold in the IPO, and holders of Class B common stock have the same stockholder rights as public stockholders, except that (i) the Class B common stock are subject to certain transfer restrictions, as described in more detail below, (ii) our founders, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed (A) to waive their redemption rights with respect to any Class B common stock and any Public Shares held by them in connection with the completion of our Business Combination and (B) to waive their rights to liquidating distributions from the Trust Account with respect to any Class B common stock held by them if the Company fails to complete our Business Combination within the prescribed time period, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete our Business Combination within such time period, (iii) the Class B common stock are shares of our Class B common stock that will automatically convert into shares of our Class A common stock at the time of our initial Business Combination, on a
one-for-one
basis, subject to adjustment pursuant to certain anti-dilution rights and (iv) are subject to registration rights. If the Company submits our Business Combination to our public stockholders for a vote, our Initial stockholders have agreed to vote any Class B common stock and any Public Shares purchased during or after the IPO in favor of our initial Business Combination.
With certain limited exceptions, the Class B common stock are not transferable, assignable or salable (except to our officers and directors and other persons or entities affiliated with the Sponsor, each of whom will be subject to the same transfer restrictions) until the earlier of (A) one year after the completion of our initial Business Combination or (B) subsequent to our initial Business Combination, (x) if the last sale price of our Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after our initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property.
v3.24.0.1
Warrants
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Warrants [Abstract]    
Warrants
Note 8 — Warrants
Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the IPO. The Public Warrants will expire five years from the completion of a Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable, and the Company will not be obligated to issue a share of Class A common stock upon exercise of a warrant unless the share of Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.
 
The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. In addition, if the shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of the Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company elects to do so, the Company will not be required to file or maintain in effect a registration statement, but it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Class A common stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied the excess of the “fair market value” less the exercise price of the warrants by (y) the fair market value and (B) 0.361. The “fair market value” shall mean the volume weighted average price of the shares of Class A common stock for the 10 trading days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent.
Redemption of Warrants For Cash
—Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants for cash:
 
   
in whole and not in part;
 
   
at a price of $0.01 per Public Warrant;
 
   
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
 
   
if, and only if, the last sale price of our Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. However, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available throughout the
30-day
redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act.
Redemption of Warrants For Shares of Class
 A Common Stock
—commencing 90 days after the warrants become exercisable, the Company may redeem the outstanding warrants for shares of Class A common stock:
 
   
in whole and not in part;
 
   
at a price equal to a number of shares of Class A common stock to be determined by reference to the agreed table set forth in the warrant agreement based on the redemption date and the “fair market value” of the Class A common stock;
 
   
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
 
   
if, and only if, the last sale price of our Class A common stock equals or exceeds $10.00 per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
The exercise price and number of shares of Class A common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of shares of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.
In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described above adjacent to “Redemption of Warrants For Cash” and “Redemption of Warrants For Shares of Class A Common Stock” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the IPO, except that (x) the Private Placement Warrants and the shares of Class A common stock issuable upon the exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (y) the Private Placement Warrants are exercisable on a cashless basis and
non-redeemable
so long as they are held by the initial purchasers or their permitted transferees and (z) the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants are entitled to registration rights. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
Additionally, as discussed in Note 5, the Working Capital Loans, and certain Promissory Notes, would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. Initially up to $1,500,000, which was increased to $3,500,000 on March 24, 2023, of such loans may be convertible into warrants.
NOTE 8 — WARRANTS
Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the IPO. The Public Warrants will expire five years from the completion of a Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable, and the Company will not be obligated to issue a share of Class A common stock upon exercise of a warrant unless the
 
share of Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.
The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. In addition, if the shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of the Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company elects to do so, the Company will not be required to file or maintain in effect a registration statement, but it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Class A common stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied the excess of the “fair market value” less the exercise price of the warrants by (y) the fair market value and (B) 0.361. The “fair market value” shall mean the volume weighted average price of the shares of Class A common stock for the 10 trading days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent.
Redemption of Warrants For Cash
—Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants for cash:
 
   
in whole and not in part;
 
   
at a price of $0.01 per Public Warrant;
 
   
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
 
   
if, and only if, the last sale price of our Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. However, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available throughout the
30-day
redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act.
Redemption of Warrants For Shares of Class
 A Common Stock
—commencing
90
days after the warrants become exercisable, the Company may redeem the outstanding warrants for shares of Class A common stock:
 
   
in whole and not in part;
 
   
at a price equal to a number of shares of Class A common stock to be determined by reference to the agreed table set forth in the warrant agreement based on the redemption date and the “fair market value” of the Class A common stock;
 
   
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
 
   
if, and only if, the last sale price of our Class A common stock equals or exceeds $10.00 per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
The exercise price and number of shares of Class A common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of shares of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.
In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described above adjacent to “Redemption of Warrants For Cash” and “Redemption of Warrants For Shares of Class A Common Stock” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the IPO, except that (x) the Private Placement Warrants and the shares of Class A common stock issuable upon the exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (y) the Private Placement Warrants are exercisable on a cashless basis and
non-redeemable
so long as they are held by the initial purchasers or their permitted transferees and (z) the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants are entitled to registration rights. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
Additionally, as discussed in Note 5, the Working
C
apital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. Initially up to $1,500,000, which was increased to $3,500,000 on March 
24
, 2023, of such loans may be convertible into warrants (see Note 11 – Subsequent Events).
v3.24.0.1
Fair Value Measurements
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Fair Value Disclosures [Abstract]    
Fair Value Measurements
Note 9— Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value
hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
   
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
   
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
   
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:


Description:
  
Level
 
  
September 30,
2023
 
  
Level
 
  
December 31,
2022
 
Assets:
                                   
Funds Held in Trust Account
     1      $ —         1      $ 290,718,297  
Liabilities:
                                   
Warrant liability—Public Warrants
     1      $ 11,500,000        1      $ 9,343,750  
Warrant liability—Private Warrants
     3      $ 3,654,125        3      $ 2,805,500  
Convertible Promissory Notes—Related Parties
     3      $ 2,645,096        3      $ 1,409,730  
Investments Held in Trust Account
As of September 30, 2023 and December 31, 2022, investments in the Company’s Trust Account consisted of $63,939,672 in a demand deposit account (and are therefore not reflected in the table above) and $290,718,297 in U.S. Money Market funds, respectively.
There were no transfers between Levels 1, 2 or 3 during the three and nine months ended September 30, 2023.
Level 1 instruments include investments in money markets. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.
Warrant Liabilities
The fair value of warrants issued by the Company in connection with the Public Offering and Private Placement had been estimated using Monte-Carlo simulations at the initial measurement date up to the date when the Public Warrants started trading on April 19, 2021. For each subsequent measurement since April 19, 2021, the public warrants were measured at the Observable Quoted Price in Active Markets. Private warrants were measured using the Modified Black-Scholes Optional Pricing Model. The estimated fair value of the private warrant liability is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury
zero-coupon
yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.
 
The aforementioned warrant liabilities are not subject to qualified hedge accounting.
As Private Placement Warrants held by FL
Co-Investment
and Intrepid Financial Partners, will not be exercisable more than five years from the effective date of the registration statement, the exercise period end date is different than other Private Placement Warrants which will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation. Accordingly, they have different inputs to the Modified Black-Scholes Optional Pricing Model.
The following table provides quantitative information regarding Level 3 inputs used to determine the fair values of Private Placement Warrants held by FL
Co-Investment
and Intrepid Financial Partners as of September 30, 2023 and December 31, 2022.
 
Inputs
  
September 30, 2023
 
 
December 31, 2022
 
Stock price
   $ 10.46     $ 10.05  
Strike price
   $ 11.50     $ 11.50  
Term (in years)
     2.40       3.15  
Volatility
     0.0     0.0
Risk-free rate
     4.82     4.12
Dividend yield
     0.00     0.00
The following table provides quantitative information regarding Level 3 fair value measurements used to determine the fair value of the Private Placement Warrants, excluding Private Placement Warrants held by FL
Co-Investment
and Intrepid Financial Partners, as of September 30, 2023 and December 31, 2022.

Inputs
  
September 30, 2023
 
 
December 31, 2022
 
Stock price
   $ 10.46     $ 10.05  
Strike price
   $ 11.50     $ 11.50  
Term (in years)
     5.30       5.25  
Volatility
     0.0     0.0
Risk-free rate
     4.50     3.91
Dividend yield
     0.00     0.00
 
The following table presents the changes in the fair value of warrant liabilities:


 
  
Public
 
  
Private
Placement
 
  
Warrant
Liabilities
 
Fair value as of December 31, 2021
  
$
8,625,000
 
  
$
4,022,250
 
  
$
12,647,250
 
Change in valuation inputs or other assumptions
     (4,456,250      (2,402,500      (6,858,750
    
 
 
    
 
 
    
 
 
 
Fair value as of March 31, 2022
    
4,168,750
 
  
1,619,750
 
  
5,788,500
 
Change in valuation inputs or other assumptions
     (1,868,750      (902,875      (2,771,625
  
 
 
 
  
 
 
 
  
 
 
 
Fair value as of June 30, 2022
  
2,300,000
 
    
716,875
 
    
3,016,875
 
Change in valuation inputs or other assumptions
     (287,500      (85,250      (372,750
    
 
 
    
 
 
    
 
 
 
Fair value as of September 30, 2022
    
2,012,500
 
  

631,625
 
  

2,644,125
 
    
 
 
    
 
 
    
 
 
 
Fair value as of December 31, 2022
    
9,343,750
 
    
2,805,500
 
    
12,149,250
 
Change in valuation inputs or other assumptions
     (1,150,000      (201,500      (1,351,500
    
 
 
    
 
 
    
 
 
 
Fair value as of March 31, 2023
    
8,193,750
 
    
2,604,000
 
    
10,797,750
 
Change in valuation inputs or other assumptions
     (3,737,500      (1,178,000      (4,915,500
  
 
 
 
  
 
 
 
  
 
 
 
Fair value as of June 30, 2023
    
4,456,250
 
    
1,426,000
 
    
5,882,250
 
Change in valuation inputs or other assumptions
     7,043,750        2,228,125        9,271,875  
    
 
 
    
 
 
    
 
 
 
Fair value as of September 30, 2023
  
$
11,500,000
 
  
$
3,654,125
 
  
$
15,154,125
 
    
 
 
    
 
 
    
 
 
 
Convertible Promissory Notes – Related Parties
The convertible promissory notes were valued using a combination of Black-Scholes and Geske models, which utilize unobservable Level 3 fair value measurement inputs. The estimated fair value of the Promissory Notes was based on the following significant inputs:

 
Inputs
  
2023 Inputs (a)
 
 
September 30, 2023
 
 
December 31, 2022
 
Exercise price
   $ 11.50     $ 11.50     $ 11.50  
Volatility
     1.9% - 2.5     2.5     1.2
Expected term to warrant expiration
     5.2 - 5.6 years       5.3 years       5.3 years  
Risk-free-rate
    
3.39% - 4.17
    4.50     3.91
Dividend yield
     0     0     0
Stock price
   $
10.13 - $10.39
    $ 10.46     $ 10.05  
 
(a)
Represents the range of inputs utilized on the respective d
a
tes of the initial valuations of the various convertible note draws and extinguishment during the nine months ended September 30, 2023.
 
The following table presents the changes in the fair value of the Level 3 Promissory Notes:

Fair value as of December 31, 2021
  
$
 
956,115
 
Proceeds received through Convertible Promissory Note on March 29, 2022
     335,000  
Initial measurement of fair value of Promissory Note
     (52,126
Change in fair value of Promissory Notes
     27,611  
    
 
 
 
Fair value as of March 31, 2022
  
$
1,266,600
 
    
 
 
 
Change in fair value of Promissory Notes
     (5,400
    
 
 
 
Fair value as of June 30, 2022
  
$
1,261,200
 
    
 
 
 
Change in fair value of Promissory Notes
     (1,200
    
 
 
 
Fair value as of September 30, 2022
  
$
1,260,000
 
    
 
 
 
Change in fair value of Promissory Notes
     149,730  
    
 
 
 
Fair value as of December 31, 2022
  
$
1,409,730
 
    
 
 
 
Principal amount of Promissory Notes amended on March 29, 2023
     726,370  
Initial measurement of fair value of Promissory Notes upon extinguishment of debt
     (42,205
Change in fair value of Promissory Notes
     3,120  
    
 
 
 
Fair value as of March 31, 2023
  
$
2,097,015
 
    
 
 
 
Proceeds received through Convertible Promissory Notes on May 12, 2023 and June 28, 2023
     445,000  
Initial measurement of fair value of Promissory Notes
     (186,194
Change in fair value of Promissory Notes
     (798,412
    
 
 
 
Fair value as of June 30, 2023
  
$
1,557,409
 
    
 
 
 
Proceeds received through Convertible Promissory Notes on August 30, 2023
     635,000  
Initial measurement of fair value of Promissory Notes
     (304,801
Change in fair value of Promissory Notes
     757,488  
    
 
 
 
Fair value as of September 30, 2023
  
$
2,645,096
 
    
 
 
 
There were no transfers in or out of Level 3 from other levels in the fair value hier
a
rchy during the three months ended September 30, 2023 and 2022.
NOTE 9 — FAIR VALUE MEASUREMENTS
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
   
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
   
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
   
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2022 and 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
Description:
  
Level
    
December 31,
2022
    
Level
    
December 31,

2021
 
Assets:
                                   
U.S. Money Market Investing in Treasury Securities Held in Trust Account
     1      $ 290,718,297        1      $ 287,516,153  
Liabilities:
                                   
Warrant liability—Public Warrants
     1        9,343,750        1      $ 8,625,000  
Warrant liability—Private Warrants
     3        2,805,500        3      $ 4,022,250  
Convertible Promissory Notes—Related Parties
     3        1,409,730        3      $ 956,115  
Investments Held in Trust Account
As of December 31, 2022 and 2021, investments in the Company’s Trust Account consisted of $290,718,297 and $287,516,153 in U.S. Money Market funds
 that invest primarily in U.S. Treasury securities
, respectively.
Except as described below, there were no transfers between Levels 1, 2 or 3 during the years ended December 31, 2022 and 2021.
Level 1 instruments include investments in money markets investing in U.S. Treasury securities. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.
Warrant Liabilities
Public Warrants were transferred from Level 3 to Level 1 when they started trading on April 19, 2021, at a value of $15,381,250.
The fair value of warrants issued by the Company in connection with the Public Offering and Private Placement had been estimated using Monte-Carlo simulations at the initial measurement date up to the date when the Public Warrants started trading on April 19, 2021. For each subsequent measurement since April 19, 2021, the public warrants were measured at the Observable Quoted Price in Active Markets. Private warrants were measured
using the Modified Black-Scholes Optional Pricing Model. The estimated fair value of the private warrant liability is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury
zero-coupon
yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.
The aforementioned warrant liabilities are not subject to qualified hedge accounting.
As Private Placement Warrants held by FL
Co-Investment
and Intrepid Financial Partners, will not be exercisable more than five years from the effective date of the registration statement, the exercise period end date is different than other Private Placement Warrants which will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation. Accordingly, they have different inputs to the Modified Black-Scholes Optional Pricing Model.
The following table provides quantitative information regarding Level 3 inputs
 used
to determine the fair values of Private Placement Warrants as of December 31, 2022 and 2021.
 
 
    
December 31,

2021
   
December 31,
2022
 
Stock price
   $ 9.72     $ 10.05  
Strike price
   $ 11.50     $ 11.50  
Term (in years)
     4.15       3.15  
Volatility
     10.8     0.0
Risk-free rate
     1.13     4.12
Dividend yield
     0.00     0.00
The following table provides quantitative information regarding Level 3 fair value measurements used to determine the fair value of the Private Placement Warrants, excluding Private Placement Warrants held by FL
Co-Investment
and Intrepid Financial Partners, as of December 31, 2022 and 2021.
 
Inputs
  
December 31,

2021
   
December 31,

2022
 
Stock price
   $ 9.72     $ 10.05  
Strike price
   $ 11.50     $ 11.50  
Term (in years)
     5.42       5.25  
Volatility
     10.8     0.0
Risk-free rate
     1.29     3.91
Dividend yi
eld
     0.00     0.00
 
The following table presents the changes in the fair value of warrant liabilities:
 
    
Public
    
Private

Placement
    
Warrant

Liabilities
 
Fair value as of December 31, 2020
  
$
—  
 
  
$
—  
 
  
$
—  
 
Initial measurement on March 1, 2021
     12,218,750        6,583,625        18,802,375  
Change in valuation inputs or other assumptions
     (3,593,750      (2,561,375      (6,155,125
    
 
 
    
 
 
    
 
 
 
Fair value as of December 31, 2021
  
$
8,625,000
 
  
$
4,022,250
 
  
$
12,647,250
 
Change in valuation inputs or other assumptions
     718,750        (1,216,750      (498,000
    
 
 
    
 
 
    
 
 
 
Fair value as of December 31, 2022
  
$
9,343,750
 
  
$
2,805,500
 
  
$
12,149,250
 
    
 
 
    
 
 
    
 
 
 
Convertible Promissory Notes – Related Parties
The convertible promissory notes were valued using a combination of Black-Scholes and Geske models, which is considered to be primarily a Level 3 fair value measurement input. The estimated fair value of the Promissory Notes was based on the following significant inputs:
 
Inputs
  
December 31,

2021
   
December 31,

2022
 
Exercise price
   $ 11.50     $ 11.50  
Volatility
     12.9     1.2
Expected term to warrant expiration
     5.4 years       5.3 years  
Risk-free-rate
     1.32     3.91
Dividend yield
     0     0
Stock price
   $ 9.71     $ 10.05  
The following table presents the changes in the fair value of the Level 3 Promissory Notes:
 
Fair value as of December 31, 2020
  
$
—  
 
Proceeds received through Convertible Promissory Note on August 11, 2021
     365,000  
Initial measurement of fair value of Promissory Note
     18,323  
Proceeds received through Convertible Promissory Note on December 29, 2021
     800,000  
Initial measurement of fair value of Promissory Note
     (143,440
Change in fair value of Promissory Notes
     (83,768
    
 
 
 
Fair value as of December 31, 2021
  
$
956,115
 
Proceeds received through Convertible Promissory Note on March 29, 2022
     335,000  
Initial measurement of fair value of Promissory Note
     (52,126
Change in fair value of Promissory Notes
     170,741  
    
 
 
 
Fair value as of December 31, 20
2
2
  
$
1,409,730
 
    
 
 
 
There were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the
years
 ended December 31, 2022 and 2021.
v3.24.0.1
Income Tax
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Tax
NOTE 10 — INCOME TAX
The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences
attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year
s
ended December 31, 2022, and December 31, 2021
,
the change in the valuation allowance was $1,210,347 and $349,999.
Internal Revenue Section 195 requires
 
start-up
 
expenditures paid or incurred in connection with investigating the creation or acquisition of an active trade or business to be capitalized for income tax purposes. The capitalized
 
start-up
 
expenditures are placed into service in the month in which an active trade or business begins and amortized ratably over 180 months. The
 
start-up
 
expenditures do not include interest, taxes, or research and experimental expenses. The tax calculation for the year ended December 31, 2022 took all of the aforementioned Section 195 guidelines into account. For the years ended December 31, 2022 and December 31, 2021, the provision for income taxes was $757,069 and $0.
The Company’s net deferred tax assets at December 31, 2022 and 2021 are as follows:
 
    
December 31,
2022
    
December 31,
2021
 
Deferred tax asset
                 
Start-up/organization
costs
   $ 1,560,694      $ 311,152  
Net operating loss carryforwards
  
 
—  
 
     39,195  
    
 
 
    
 
 
 
Total deferred tax assets
     1,560,694        350,347  
Valuation allowance
     (1,560,694      (350,347
    
 
 
    
 
 
 
Deferred tax assets, net of allowance
  
$
—  
 
  
$
—  
 
    
 
 
    
 
 
 
The income tax provision for the years ended December 31, 2022 and 2021 consists of the following:
 
 
  
Years Ended December 31,
 
 
  
2022
 
  
2021
 
Current
                 
Federal
   $ 757,069      $ —    
State
     —          —    
Deferred
                 
Federal
     (1,210,347      (349,999
State
  
 
—  
 
  
 
—  
 
Change in valuation allowance

  
 
1,210,347
 
  
 
349,999
 
    
 
 
    
 
 
 
Income tax provision
   $ 757,069      $ —    
    
 
 
    
 
 
 
As
of December 31, 2022, and 2021, the Company had zero and $186,642 of U.S. federal net operating loss carryovers available to offset future taxable income. Net operating losses generated do not expire.
There were no unrecognized tax benefits as of December 31, 2022 and December 31, 2021. No amounts were accrued for the payment of interest and penalties as of December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company files income tax returns in the U.S. federal and state of Texas jurisdictions. The apportionment rate in Texas is currently 0.0%. The Company’s tax returns for the year
s
 ended December 31, 2021 and 2020 remain open and subject to examination.

A reconciliation of the federal income tax rate to the Company’s effective tax rate at December 31, 2022 and 2021 is as follows:

 
 
  
Years Ended December 31,
 
 
  
 2022 
 
 
 2021 
 
Income tax at statutory rate
     21.0     21.0
Change in valuation allowance
     (66.0 )%     8.2
Fair value of warrant adjustment
     3.7     (29.2 )%
 
    
 
 
   
 
 
 
Income tax expense
     (41.3 )%     0.0
    
 
 
   
 
 
 
v3.24.0.1
Subsequent Events
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Subsequent Events [Abstract]    
Subsequent Events
Note 10 — Subsequent Events
The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company, other than as previously described herein or listed below, did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
On October 13, 2023 and November 6, 2023, the Company filed
amendments
to the Proxy Statement for the purpose of addressing SEC Staff comments.
NOTE 11 — SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company, other than as previously described herein or listed below, did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
Q1 2023 Promissory Note
. On February 6, 2023, the Company issued an unsecured promissory note to the Sponsor (the “Q1 2023 Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $535,000
. The Q1 2023 Promissory Note is
non-interest
bearing and payable on the consummation of the Company’s Business Combination. On February 7, 2023, the Q1 2023 Promissory Note was fully drawn down by the Company.
Trust Account Liquidation
. On February 21, 2023, to mitigate the risk of us being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act), the investments in U.S. government securities or money market funds held in the Trust Account were liquidated to thereafter be held in cash (which may include an interest bearing demand deposit account at a national bank) until earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s stockholders.
Extension Amendment
. On February 27, 2023, at a special meeting of stockholders, the Company’s stockholders voted to approve an amendment (the “Extension Amendment Proposal”) to the amended and restated certificate of incorporation to extend the date by which the Company must complete a business combination (the “Extension”) from March 1, 2023 to September 1, 2023 (the “Extended Date”). In connection with the Extension, stockholders holding 20,317,255 shares of Class A Common Stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account, representing approximately 70.67% of our issued and outstanding Class A ordinary shares. As a result, $206,121,060 (approximately $10.15 per share) was removed from the Trust Account to pay such redeeming holders on March 2, 2023.
Amended Letter Agreement
. On March 24, 2023, the Company entered into an amended Letter Agreement, which amended that certain Letter Agreement, dated as of February 24, 2021, by and among the Company, Flame Acquisition Sponsor LLC, FL
Co-Investment
LLC, Intrepid Financial Partners L.L.C., to increase the amount of convertible promissory notes allowed from up to
 $
1,500,000
to up to $
3,500,000
.
Promissory Note Amendments
. On March 28, 2023, the Company and Flame Acquisition Sponsor LLC entered into amendments to each of the Q3 2022 Promissory Note, Q4 2022 Promissory Note and Q1 2023 Promissory Note, pursuant to which loans made under such notes are, at the lender’s discretion, convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant.
On February 27, 2023, in connection with the Extension, the Company filed an amendment (the “Extension Amendment”) to its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware. The Extension Amendment extends the date by which the Company must consummate its initial business combination from March 1, 2023 to September 1, 2023.
v3.24.0.1
Significant Accounting Policies (Policies)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Accounting Policies [Abstract]    
Basis of Presentation
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form
10-Q
and Article 8 of Regulation
S-X
of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
 
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form
10-K
as filed with the SEC on March 31, 2023, as well as the Company’s Current Reports on Form
8-K.
The accompanying condensed balance sheet as of December 31, 2022 has been derived from our audited financial statements included in that Annual Report. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods.
Basis of Presentation
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for annual financial information and in accordance with the instructions to Form
10-K and
Article 8 of
Regulation S-X of
the U.S. Securities and Exchange Commission (“SEC”).
Emerging Growth Company Status
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies, but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences
in
accounting standards used.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant accounting estimates include inputs utilized to fair value warrant liabilities and convertible promissory notes. Actual results could differ from those estimates.
Use of Estimates
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022, respectively.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and 2021.
Marketable Securities Held in Trust Account
Marketable Securities Held in Trust Account
At December 31, 2022, the Trust Account had $290,718,297 in marketable securities. As discussed in Note 1, during the nine months ended September 30, 2023, the investments previously held in the Trust Account were liquidated with all funds in the Trust Account to be held in cash (which may include an interest bearing demand deposit account). During the nine months ended September 30, 2023 and the year ended December 31, 2022, the Company withdrew $490,151 and $786,918, respectively, of interest income from the Trust Account to pay its tax obligations.
 
Additionally, as discussed further below, approximately $230.1 million was removed from the Trust Account to pay redeeming holders during the nine months ended September 30, 2023.

Marketable securities held in the Trust Account
are
classified as “Trading Securities” in accordance with ASC 320, “Investments – Debt Securities” and are reported at fair value with unrealized gains or losses included in earnings of the current period.
Marketable Securities Held in Trust Account
At December 31, 2022 and 2021, the Trust Account had $290,718,297 and $287,516,153 held in marketable securities, respectively. During the period ended December 31, 2022, the Company withdrew $786,918 of interest income from the Trust Account to pay its tax obligations. During the period ended December 31, 2021, the Company did not withdraw any interest income from the Trust Account to pay its tax obligations.
 
Marketable securities held in the Trust Account are classified as “Trading Securities” in accordance with ASC 320, “Investments – Debt Securities” and are reported at fair value with unrealized gains or losses included in earnings of the current period.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At September 30, 2023 and December 31, 2022, the Company did not experience losses on this account.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At December 31, 2022 and 2021, the Company did not experience losses on this account.
Common Stock Subject to Possible Redemption
Common Stock Subject to Possible Redemption
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity. The Company’s redeemable Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of September 30, 2023 and December 31, 2022,
6,104,682 and 28,750,000
shares of Class A common stock subject to possible redemption, representing all outstanding shares of redeemable Class A common stock on those dates, are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets, respectively.
Under ASC
480-10-S99,
the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of our initial public offering, we recognized the remeasurement amount from initial book value to redemption amount, which, resulted in charges against additional
paid-in
capital (to the extent available) and accumulated deficit.
Amount remeasured in 2023 represents investment income accrued in the Trust Account during the period reduced by the amounts of Delaware franchise tax and income taxes paid and payable for 2021, 2022 and 2023, net of cash withdrawn from the Trust Account to pay these obligations.
On February 23, 2023, the Company was notified by stockholders holding 20,317,255 shares of Class A common stock that they exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $206,121,060 (approximately $10.15 per share) was removed from the Trust Account to pay such redeeming holders on March 2, 2023.
On August 29, 2023, the Company was notified by stockholders holding 2,328,063 shares of Class A common stock that they exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $24,008,096 (approximately $10.31 per share) was removed from the Trust Account to pay such redeeming holders on August 31, 2023.
 
At September 30, 2023 and December 31, 2022, the Class A common stock reflected in the condensed balance sheets is reconciled in the following table:
 
 
  
Shares
 
  
Value
 
Gross proceeds from Initial Public Offering
     28,750,000      $ 287,500,000  
Less:
                 
Common stock issuance costs
     —         (6,326,922
Proceeds allocated to public warrants
     —         (12,218,750
Plus:
                 
Remeasurement of Class A common stock subject to possible
redemption
     —         21,392,680  
    
 
 
    
 
 
 
Contingently redeemable common stock at December 31, 2022
  
 
28,750,000
 
  
 
290,347,008
 
Less:
                 
Redemptions of Class A common stock
     (22,645,318      (230,129,156
Plus:
                 
Remeasurement of Class A common stock subject to possible
redemption
     —         2,905,703  
    
 
 
    
 
 
 
Contingently redeemable Class A common stock at September 30, 2023
  
 
6,104,682
 
  
$
63,123,555
 
    
 
 
    
 
 
 
Class A Common Stock Subject to Possible Redemption
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity (deficit).
 
The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 
31
,
2022
and
2021
,
28,750,000
shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.
Under ASC
480-10-S99,
the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of our initial public offering, we recognized the accretion from initial book value to redemption amount, which, resulted in charges against additional
paid-in
capital (to the extent available) and accumulated deficit.
The amount accreted in 2022 represents investment income accrued in the Trust Account since the date of the IPO reduced by the amounts of Delaware franchise tax and income taxes paid and payable for 2021 and 2022, net of cash withdrawn from the Trust Account to pay these
obligations.

At December 31, 2022 and 2021, the Class A common stock reflected in the balance sheets is reconciled in the following table:
 
Gross proceeds from Initial Public Offering
   $ 287,500,000  
Less:
        
Common stock issuance costs
     (6,326,922
Proceeds allocated to public warrants
     (12,218,750
Plus:
        
Remeasurement of Class A common stock to possible redemption
     18,545,672  
    
 
 
 
Contingently redeemable common stock at December 31, 2021
  
 
287,500,000
 
    
 
 
 
Plus:
        
Remeasurement of Class A common stock to possible redemption
     2,847,008  
    
 
 
 
Contingently redeemable common stock at December 31, 2022
  
$
290,347,008
 
    
 
 
 
 
On February 23, 2023
, in connection with the Extension described in Note 11
,
the
Company was notified by stockholders holding 20,317,255 shares of Class A Common Stock that they exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $206,121,060 (approximately $10.15 per share) was removed from the Trust Account to pay such redeeming holders on March 2, 2023.
Class A Common Stock
Class A Common Stock
On August 22, 2023, we issued an aggregate of 7,187,500 shares of Class A common stock to the Sponsor, FL
Co-Investment,
Intrepid Financial Partners, our independent directors and certain of our executive officers, upon the conversion of an equal number of shares of Class B common stock (the “Class B Conversion”). The 7,187,500 shares of Class A common stock issued in connection with the Class B Conversion are subject to the same restrictions as applied to the shares of Class B common stock before the Class B Conversion, including, among other things, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination, as described in the prospectus for the Initial Public Offering (“IPO”) described below. After the Class B Conversion, no shares of Class B common stock remained outstanding.
 
Net (Loss) Income Per Share of Common Stock
Net (Loss) Income Per Share of Common Stock
The Company complies with accounting and disclosure requirements of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260, “Earnings Per Share.” Net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of shares of common stock outstanding for the period. Subsequent remeasurement of the redeemable Class A common stock is excluded from (loss) income per share of common stock as the redemption value approximates fair value. Net (loss) income per share of common stock is computed by dividing the pro rata net (loss) income between the shares of Class A common stock and the shares of Class B common stock by the weighted average number of shares of common stock outstanding for each of the periods. The calculation of diluted (loss) income per share does not consider the effect of the warrants issued in connection with the IPO, as well as warrants issuable upon the exercise of the conversion option on outstanding working capital loans, since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable for
 
25,431,370
and 23,625,000 shares of Class A common stock in the aggregate as of September 30, 2023 and 2022, respectively.
 
The following table reflects the calculation of basic and diluted net (loss) income
per
share of common stock (in dollars, except share amounts):

 
    
For the Three Months Ended
September 30,
   
For the Nine Months Ended
September 30,
 
    
2023
   
2022
   
2023
   
2022
 
Common stock subject to possible redemption
        
Numerator:
        
Net (loss) income allocable to Class A common stock subject to possible redemption
   $ (5,571,661   $ (153,400   $ (2,167,037   $ 7,243,954  
Denominator:
        
Weighted Average Redeemable Class A common stock, Basic and Diluted
     8,169,859       28,750,000       12,660,640       28,750,000  
  
 
 
   
 
 
   
 
 
   
 
 
 
Basic and Diluted net (loss) income per share, Redeemable Class A common stock
   $ (0.68   $ (0.01   $ (0.17   $ 0.25  
  
 
 
   
 
 
   
 
 
   
 
 
 
Non-Redeemable
common stock
        
Numerator:
        
Net (loss) income allocable to Class A and Class B common stock not subject to redemption
   $ (4,901,714   $ (38,350   $ (1,230,237   $ 1,810,988  
Denominator:
        
Weighted Average
Non-redeemable
Class A and Class B common stock, Basic and Diluted
     7,187,500       7,187,500       7,187,500       7,187,500  
  
 
 
   
 
 
   
 
 
   
 
 
 
Basic and diluted net (loss) income per share of
Non-redeemable
Class A and Class B common stock
   $ (0.68   $ (0.01   $ (0.17   $ 0.25  
  
 
 
   
 
 
   
 
 
   
 
 
 
Net (Loss) Income Per Share of Common Stock
The Company complies with accounting and disclosure requirements of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260, “Earnings Per Share.” Net (loss) income per share of common stock is computed by dividing net income by the weighted average number of shares of common stock outstanding for the period. Subsequent remeasurement of the redeemable Class A common stock is excluded from income per share of common stock as the redemption value approximates fair value. Net (loss) income per share of common stock is computed by dividing the pro rata net (loss) income between the shares of Class A common stock and the shares of Class B common stock by the weighted average number of shares of common stock outstanding for each of the periods. The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the IPO, as well as warrants issuable upon the exercise of the conversion option on outstanding working capital loans, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for
23,625,000
and 23,290,000
shares of Class A common stock in the aggregate
 as of December 31, 2022 and 2021, respectively
.
The following table reflects the calculation of basic and diluted net (loss) income per share of common stock (in dollars, except share amounts):
 
 
  
For the Years Ended
December 31,
 
 
  
2022
 
  
2021
 
Common stock subject to possible redemption
                 
Numerator:
                 
Net (loss) income allocable to Class A common stock subject to possible redemption
   $ (2,072,758    $ 3,301,319  
Denominator:
                 
Weighted Average Redeemable Class A common stock, Basic and Diluted
     28,750,000        24,417,808  
Basic and Diluted net (loss) income per share, Redeemable Class A common stock
   $ (0.07    $ 0.14  
Non-Redeemable
Ordinary shares
                 
Numerator:
                 
Net (loss) income allocable to Class B common stock not subject to redemption
   $ (518,190    $ 971,759  
Denominator:
                 
Weighted
Average Non-Redeemable common
stock, Basic and Diluted
     7,187,500        7,187,500  
Basic and diluted net (loss) income per share
   $ (0.07    $ 0.14  
Offering Costs  
Offering Costs
The Company complies with the requirements of ASC
340-10-S99-1
and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering and that were allocated among common stock subject to possible redemption and to stockholders’ deficit upon the completion of the IPO. Accordingly, during the period ended December 31,
2021
, offering
costs
totaling $6,607,751 were charged to
 
temporary equity and stockholders’ deficit (consisting of $5,750,000 of underwriting fee and $857,751 of other offering costs). Of the total transaction cost, $280,829 was allocated to warrants as a
non-operating
expense in the statement of operations for the
year
 ended December 31, 2021, with the rest of the offering costs allocated among common stock subject to possible redemption and to stockholders’ deficit. The transaction costs were allocated based on the with and without method, compared to the total offering proceeds, between the fair value of the public warrant liabilities and the Class A common stock.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the condensed balance sheets.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value
Measurement”
approximates the carrying amounts represented in the balance sheets.
Derivative Warrant Liabilities
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period.
The Company accounts for its 22,125,000 common stock warrants issued in connection with its Initial Public Offering (14,375,000) and Private Placement (7,750,000) as derivative warrant liabilities in accordance with ASC
815-40.
Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed
statements of operations. The fair value of warrants issued by the Company in connection with the Initial Public Offering and Private Placement had been estimated using Monte-Carlo simulations at the initial measurement date. However, for each subsequent measurement, beginning on April 19, 2021, the public warrants were measured at the Observable Quoted Price in Active Markets and the private warrants were measured using the Modified Black-Scholes Option Pricing Model.
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period.
The Company accounts for its 22,125,000 common stock warrants issued in connection with its Initial Public Offering (14,375,000) and Private Placement (7,750,000) as derivative warrant liabilities in accordance with ASC
815-40.
Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of warrants issued by the Company in connection with the Initial Public Offering and Private Placement had been estimated using Monte-Carlo simulations at the initial measurement date. However, for each subsequent measurement, beginning on April 19, 2021, the public warrants were measured at the Observable Quoted Price in Active Markets and the private warrants were measured using the Modified Black-Scholes Option Pricing Model.
Convertible Promissory Notes—Related Party
Convertible Promissory Notes—Related Party
The Company accounts for the convertible promissory notes under ASC 815. The Company has made the election under
815-15-25
to account for the notes under the fair value option. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Differences between the face value of the note and fair value at issuance are recognized as either an expense in the condensed statement of operations (if issued at a premium) or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as
non-cash
gains or losses in the condensed statements of operations.  
Convertible Promissory Notes—Related Party
The Company accounts for the convertible promissory notes under ASC 815. The Company has made the election under ASC
815-15-25
to account for the notes under the fair value option. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Differences between the face value of the note and fair value at issuance are recognized as either an expense in the statement of operations (if issued at a premium) or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as
non-cash
gains or losses in the statements of operations.
Income Taxes
Income Taxes
The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC 740 also requires that an annual effective tax rate be determined and that such annual effective rate be applied to
year-to-date
income in interim periods. Using provisions of ASC 740 that allow certain tax items to be recorded in the interim period in which these items are reported, the Company’s effective tax rate was negative 1.42% and 156.66% for the three months ended September 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three months ended September 30, 2023 and 2022, due primarily to changes in fair value of the warrant liability, which are not included in taxable income, non-deductible merger related expenditures, and the valuation allowance on the deferred tax assets.
The Company’s effective tax rate was negative 30.08% and 5.53% for the nine months ended September 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the nine months ended September 30, 2023 and 2022, due primarily to changes in fair value of the warrant liability, which are not included in taxable income, non-deductible merger related expenditures, and the valuation allowance on the deferred tax assets.
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position
taken
or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
 
The Company has identified the United States as its only “major” tax jurisdiction.
The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Income Taxes
The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
 
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in annual period, disclosure and transition.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were
no
unrecognized tax benefits and
no
amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company has identified the United States as its only “major” tax jurisdiction.
The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Standards
Recent Accounting Standards
In August 2020, the FASB issued ASU
2020-06,
“Debt-Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic
815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU
2020-06”),
which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for scope exception, and it simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06
is effective no later than January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently reviewing what impact, if any, adoption will have on the Company’s financial position, results of operations or cash flows.
The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.
Recent Accounting Standards
In August 2020, the FASB issued
ASU 2020-06, “Debt-Debt
with Conversion and Other Options
(Subtopic 470-20)
and Derivatives and Hedging-Contracts in Entity’s Own Equity
(Subtopic 815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”
(“ASU 2020-06”),
which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for scope exception, and it simplifies the diluted earnings per share calculation in certain areas.
ASU 2020-06
is effective no later than January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently reviewing what impact, if any, adoption will have on the Company’s financial position, results of operations or cash flows.
The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.
v3.24.0.1
Significant Accounting Policies (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Earnings Per Share [Abstract]    
Summary of Reconciled the Class A Ordinary Shares
At September 30, 2023 and December 31, 2022, the Class A common stock reflected in the condensed balance sheets is reconciled in the following table:
 
 
  
Shares
 
  
Value
 
Gross proceeds from Initial Public Offering
     28,750,000      $ 287,500,000  
Less:
                 
Common stock issuance costs
     —         (6,326,922
Proceeds allocated to public warrants
     —         (12,218,750
Plus:
                 
Remeasurement of Class A common stock subject to possible
redemption
     —         21,392,680  
    
 
 
    
 
 
 
Contingently redeemable common stock at December 31, 2022
  
 
28,750,000
 
  
 
290,347,008
 
Less:
                 
Redemptions of Class A common stock
     (22,645,318      (230,129,156
Plus:
                 
Remeasurement of Class A common stock subject to possible
redemption
     —         2,905,703  
    
 
 
    
 
 
 
Contingently redeemable Class A common stock at September 30, 2023
  
 
6,104,682
 
  
$
63,123,555
 
    
 
 
    
 
 
 
At December 31, 2022 and 2021, the Class A common stock reflected in the balance sheets is reconciled in the following table:
 
Gross proceeds from Initial Public Offering
   $ 287,500,000  
Less:
        
Common stock issuance costs
     (6,326,922
Proceeds allocated to public warrants
     (12,218,750
Plus:
        
Remeasurement of Class A common stock to possible redemption
     18,545,672  
    
 
 
 
Contingently redeemable common stock at December 31, 2021
  
 
287,500,000
 
    
 
 
 
Plus:
        
Remeasurement of Class A common stock to possible redemption
     2,847,008  
    
 
 
 
Contingently redeemable common stock at December 31, 2022
  
$
290,347,008
 
    
 
 
 
Summary of basic and diluted loss per ordinary share
The following table reflects the calculation of basic and diluted net (loss) income
per
share of common stock (in dollars, except share amounts):

 
    
For the Three Months Ended
September 30,
   
For the Nine Months Ended
September 30,
 
    
2023
   
2022
   
2023
   
2022
 
Common stock subject to possible redemption
        
Numerator:
        
Net (loss) income allocable to Class A common stock subject to possible redemption
   $ (5,571,661   $ (153,400   $ (2,167,037   $ 7,243,954  
Denominator:
        
Weighted Average Redeemable Class A common stock, Basic and Diluted
     8,169,859       28,750,000       12,660,640       28,750,000  
  
 
 
   
 
 
   
 
 
   
 
 
 
Basic and Diluted net (loss) income per share, Redeemable Class A common stock
   $ (0.68   $ (0.01   $ (0.17   $ 0.25  
  
 
 
   
 
 
   
 
 
   
 
 
 
Non-Redeemable
common stock
        
Numerator:
        
Net (loss) income allocable to Class A and Class B common stock not subject to redemption
   $ (4,901,714   $ (38,350   $ (1,230,237   $ 1,810,988  
Denominator:
        
Weighted Average
Non-redeemable
Class A and Class B common stock, Basic and Diluted
     7,187,500       7,187,500       7,187,500       7,187,500  
  
 
 
   
 
 
   
 
 
   
 
 
 
Basic and diluted net (loss) income per share of
Non-redeemable
Class A and Class B common stock
   $ (0.68   $ (0.01   $ (0.17   $ 0.25  
  
 
 
   
 
 
   
 
 
   
 
 
 
The following table reflects the calculation of basic and diluted net (loss) income per share of common stock (in dollars, except share amounts):
 
 
  
For the Years Ended
December 31,
 
 
  
2022
 
  
2021
 
Common stock subject to possible redemption
                 
Numerator:
                 
Net (loss) income allocable to Class A common stock subject to possible redemption
   $ (2,072,758    $ 3,301,319  
Denominator:
                 
Weighted Average Redeemable Class A common stock, Basic and Diluted
     28,750,000        24,417,808  
Basic and Diluted net (loss) income per share, Redeemable Class A common stock
   $ (0.07    $ 0.14  
Non-Redeemable
Ordinary shares
                 
Numerator:
                 
Net (loss) income allocable to Class B common stock not subject to redemption
   $ (518,190    $ 971,759  
Denominator:
                 
Weighted
Average Non-Redeemable common
stock, Basic and Diluted
     7,187,500        7,187,500  
Basic and diluted net (loss) income per share
   $ (0.07    $ 0.14  
v3.24.0.1
Related Party Transactions (Tables)
9 Months Ended
Sep. 30, 2023
Debt Instruments [Abstract]  
Schedule Of Fair Value Of Debt Instrument
The following tables presents the balances of the convertible promissory notes – related parties, at fair value and the promissory notes to related parties as of the respective period ends:

 
 
Principal Value
 
 
Fair Value
 
 
 
$ Amount
 
 
September 30, 2023
 
 
December 31, 2022
 
Convertible notes –related parties, at fair value
                          
First Working Capital Loan
   $ 365,000      $ 292,000      $ 343,034  
Second Working Capital Loan
     800,000        640,000        751,856  
Third Working Capital Loan
     335,000        268,000        314,840  
Q3 2022 Promissory Note
     170,000        136,000         
Q4 2022 Promissory Note
     200,000        160,000         
Q1 2023 Promissory Note
     356,370        285,096         
First Q2 2023 Promissory Note
     395,000        316,000         
Fourth Q2 2023 Promissory Note
     50,000        40,000         
First Q3 2023 Promissory Note
     635,000        508,000         
    
 
 
    
 
 
    
 
 
 
Total
  
$
3,306,370
 
  
$
2,645,096
 
  
$
1,409,730
 
Promissory notes to related parties
                          
Q3 2022 Promissory Note
  
$
     $      $ 170,000  
Q4 2022 Promissory Note
                   200,000  
Q1 2023 Promissory Note
     178,630        178,630         
Second Q2 2023 Promissory Note
     355,000        355,000         
Third Q2 2023 Promissory Note
     100,000        100,000         
Second Q3 2023 Promissory Note
     495,000        495,000         
    
 
 
    
 
 
    
 
 
 
Total
  
$
1,128,630
 
  
$
1,128,630
 
  
$
370,000
 
v3.24.0.1
Fair Value Measurements (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Schedule of Assets Measured at Fair Value on a Recurring Basis
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:


Description:
  
Level
 
  
September 30,
2023
 
  
Level
 
  
December 31,
2022
 
Assets:
                                   
Funds Held in Trust Account
     1      $ —         1      $ 290,718,297  
Liabilities:
                                   
Warrant liability—Public Warrants
     1      $ 11,500,000        1      $ 9,343,750  
Warrant liability—Private Warrants
     3      $ 3,654,125        3      $ 2,805,500  
Convertible Promissory Notes—Related Parties
     3      $ 2,645,096        3      $ 1,409,730  
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2022 and 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
Description:
  
Level
    
December 31,
2022
    
Level
    
December 31,

2021
 
Assets:
                                   
U.S. Money Market Investing in Treasury Securities Held in Trust Account
     1      $ 290,718,297        1      $ 287,516,153  
Liabilities:
                                   
Warrant liability—Public Warrants
     1        9,343,750        1      $ 8,625,000  
Warrant liability—Private Warrants
     3        2,805,500        3      $ 4,022,250  
Convertible Promissory Notes—Related Parties
     3        1,409,730        3      $ 956,115  
Schedule of Fair Value Measurements Using Monte Carlo Simulation Model
The following table provides quantitative information regarding Level 3 fair value measurements used to determine the fair value of the Private Placement Warrants, excluding Private Placement Warrants held by FL
Co-Investment
and Intrepid Financial Partners, as of September 30, 2023 and December 31, 2022.

Inputs
  
September 30, 2023
 
 
December 31, 2022
 
Stock price
   $ 10.46     $ 10.05  
Strike price
   $ 11.50     $ 11.50  
Term (in years)
     5.30       5.25  
Volatility
     0.0     0.0
Risk-free rate
     4.50     3.91
Dividend yield
     0.00     0.00
The following table provides quantitative information regarding Level 3 fair value measurements used to determine the fair value of the Private Placement Warrants, excluding Private Placement Warrants held by FL
Co-Investment
and Intrepid Financial Partners, as of December 31, 2022 and 2021.
 
Inputs
  
December 31,

2021
   
December 31,

2022
 
Stock price
   $ 9.72     $ 10.05  
Strike price
   $ 11.50     $ 11.50  
Term (in years)
     5.42       5.25  
Volatility
     10.8     0.0
Risk-free rate
     1.29     3.91
Dividend yi
eld
     0.00     0.00
 
Schedule of Changes in the Fair Value of Warrant Liabilities
The following table presents the changes in the fair value of warrant liabilities:


 
  
Public
 
  
Private
Placement
 
  
Warrant
Liabilities
 
Fair value as of December 31, 2021
  
$
8,625,000
 
  
$
4,022,250
 
  
$
12,647,250
 
Change in valuation inputs or other assumptions
     (4,456,250      (2,402,500      (6,858,750
    
 
 
    
 
 
    
 
 
 
Fair value as of March 31, 2022
    
4,168,750
 
  
1,619,750
 
  
5,788,500
 
Change in valuation inputs or other assumptions
     (1,868,750      (902,875      (2,771,625
  
 
 
 
  
 
 
 
  
 
 
 
Fair value as of June 30, 2022
  
2,300,000
 
    
716,875
 
    
3,016,875
 
Change in valuation inputs or other assumptions
     (287,500      (85,250      (372,750
    
 
 
    
 
 
    
 
 
 
Fair value as of September 30, 2022
    
2,012,500
 
  

631,625
 
  

2,644,125
 
    
 
 
    
 
 
    
 
 
 
Fair value as of December 31, 2022
    
9,343,750
 
    
2,805,500
 
    
12,149,250
 
Change in valuation inputs or other assumptions
     (1,150,000      (201,500      (1,351,500
    
 
 
    
 
 
    
 
 
 
Fair value as of March 31, 2023
    
8,193,750
 
    
2,604,000
 
    
10,797,750
 
Change in valuation inputs or other assumptions
     (3,737,500      (1,178,000      (4,915,500
  
 
 
 
  
 
 
 
  
 
 
 
Fair value as of June 30, 2023
    
4,456,250
 
    
1,426,000
 
    
5,882,250
 
Change in valuation inputs or other assumptions
     7,043,750        2,228,125        9,271,875  
    
 
 
    
 
 
    
 
 
 
Fair value as of September 30, 2023
  
$
11,500,000
 
  
$
3,654,125
 
  
$
15,154,125
 
    
 
 
    
 
 
    
 
 
 
The following table presents the changes in the fair value of warrant liabilities:
 
    
Public
    
Private

Placement
    
Warrant

Liabilities
 
Fair value as of December 31, 2020
  
$
—  
 
  
$
—  
 
  
$
—  
 
Initial measurement on March 1, 2021
     12,218,750        6,583,625        18,802,375  
Change in valuation inputs or other assumptions
     (3,593,750      (2,561,375      (6,155,125
    
 
 
    
 
 
    
 
 
 
Fair value as of December 31, 2021
  
$
8,625,000
 
  
$
4,022,250
 
  
$
12,647,250
 
Change in valuation inputs or other assumptions
     718,750        (1,216,750      (498,000
    
 
 
    
 
 
    
 
 
 
Fair value as of December 31, 2022
  
$
9,343,750
 
  
$
2,805,500
 
  
$
12,149,250
 
    
 
 
    
 
 
    
 
 
 
Promissory Note [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Schedule of Fair Value Measurements Using Monte Carlo Simulation Model
The convertible promissory notes were valued using a combination of Black-Scholes and Geske models, which utilize unobservable Level 3 fair value measurement inputs. The estimated fair value of the Promissory Notes was based on the following significant inputs:

 
Inputs
  
2023 Inputs (a)
 
 
September 30, 2023
 
 
December 31, 2022
 
Exercise price
   $ 11.50     $ 11.50     $ 11.50  
Volatility
     1.9% - 2.5     2.5     1.2
Expected term to warrant expiration
     5.2 - 5.6 years       5.3 years       5.3 years  
Risk-free-rate
    
3.39% - 4.17
    4.50     3.91
Dividend yield
     0     0     0
Stock price
   $
10.13 - $10.39
    $ 10.46     $ 10.05  
 
(a)
Represents the range of inputs utilized on the respective d
a
tes of the initial valuations of the various convertible note draws and extinguishment during the nine months ended September 30, 2023.
The convertible promissory notes were valued using a combination of Black-Scholes and Geske models, which is considered to be primarily a Level 3 fair value measurement input. The estimated fair value of the Promissory Notes was based on the following significant inputs:
 
Inputs
  
December 31,

2021
   
December 31,

2022
 
Exercise price
   $ 11.50     $ 11.50  
Volatility
     12.9     1.2
Expected term to warrant expiration
     5.4 years       5.3 years  
Risk-free-rate
     1.32     3.91
Dividend yield
     0     0
Stock price
   $ 9.71     $ 10.05  
Schedule of Changes in the Fair Value of Warrant Liabilities
The following table presents the changes in the fair value of the Level 3 Promissory Notes:

Fair value as of December 31, 2021
  
$
 
956,115
 
Proceeds received through Convertible Promissory Note on March 29, 2022
     335,000  
Initial measurement of fair value of Promissory Note
     (52,126
Change in fair value of Promissory Notes
     27,611  
    
 
 
 
Fair value as of March 31, 2022
  
$
1,266,600
 
    
 
 
 
Change in fair value of Promissory Notes
     (5,400
    
 
 
 
Fair value as of June 30, 2022
  
$
1,261,200
 
    
 
 
 
Change in fair value of Promissory Notes
     (1,200
    
 
 
 
Fair value as of September 30, 2022
  
$
1,260,000
 
    
 
 
 
Change in fair value of Promissory Notes
     149,730  
    
 
 
 
Fair value as of December 31, 2022
  
$
1,409,730
 
    
 
 
 
Principal amount of Promissory Notes amended on March 29, 2023
     726,370  
Initial measurement of fair value of Promissory Notes upon extinguishment of debt
     (42,205
Change in fair value of Promissory Notes
     3,120  
    
 
 
 
Fair value as of March 31, 2023
  
$
2,097,015
 
    
 
 
 
Proceeds received through Convertible Promissory Notes on May 12, 2023 and June 28, 2023
     445,000  
Initial measurement of fair value of Promissory Notes
     (186,194
Change in fair value of Promissory Notes
     (798,412
    
 
 
 
Fair value as of June 30, 2023
  
$
1,557,409
 
    
 
 
 
Proceeds received through Convertible Promissory Notes on August 30, 2023
     635,000  
Initial measurement of fair value of Promissory Notes
     (304,801
Change in fair value of Promissory Notes
     757,488  
    
 
 
 
Fair value as of September 30, 2023
  
$
2,645,096
 
    
 
 
 
The following table presents the changes in the fair value of the Level 3 Promissory Notes:
 
Fair value as of December 31, 2020
  
$
—  
 
Proceeds received through Convertible Promissory Note on August 11, 2021
     365,000  
Initial measurement of fair value of Promissory Note
     18,323  
Proceeds received through Convertible Promissory Note on December 29, 2021
     800,000  
Initial measurement of fair value of Promissory Note
     (143,440
Change in fair value of Promissory Notes
     (83,768
    
 
 
 
Fair value as of December 31, 2021
  
$
956,115
 
Proceeds received through Convertible Promissory Note on March 29, 2022
     335,000  
Initial measurement of fair value of Promissory Note
     (52,126
Change in fair value of Promissory Notes
     170,741  
    
 
 
 
Fair value as of December 31, 20
2
2
  
$
1,409,730
 
    
 
 
 
Other Private Placement Warrants [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Schedule of Fair Value Measurements Using Monte Carlo Simulation Model
The following table provides quantitative information regarding Level 3 inputs used to determine the fair values of Private Placement Warrants held by FL
Co-Investment
and Intrepid Financial Partners as of September 30, 2023 and December 31, 2022.
 
Inputs
  
September 30, 2023
 
 
December 31, 2022
 
Stock price
   $ 10.46     $ 10.05  
Strike price
   $ 11.50     $ 11.50  
Term (in years)
     2.40       3.15  
Volatility
     0.0     0.0
Risk-free rate
     4.82     4.12
Dividend yield
     0.00     0.00
The following table provides quantitative information regarding Level 3 inputs
 used
to determine the fair values of Private Placement Warrants as of December 31, 2022 and 2021.
 
 
    
December 31,

2021
   
December 31,
2022
 
Stock price
   $ 9.72     $ 10.05  
Strike price
   $ 11.50     $ 11.50  
Term (in years)
     4.15       3.15  
Volatility
     10.8     0.0
Risk-free rate
     1.13     4.12
Dividend yield
     0.00     0.00
v3.24.0.1
Income Tax (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Summary Of Net Deferred Tax Assets
The Company’s net deferred tax assets at December 31, 2022 and 2021 are as follows:
 
    
December 31,
2022
    
December 31,
2021
 
Deferred tax asset
                 
Start-up/organization
costs
   $ 1,560,694      $ 311,152  
Net operating loss carryforwards
  
 
—  
 
     39,195  
    
 
 
    
 
 
 
Total deferred tax assets
     1,560,694        350,347  
Valuation allowance
     (1,560,694      (350,347
    
 
 
    
 
 
 
Deferred tax assets, net of allowance
  
$
—  
 
  
$
—  
 
    
 
 
    
 
 
 
Summary Of Income Tax Provision
The income tax provision for the years ended December 31, 2022 and 2021 consists of the following:
 
 
  
Years Ended December 31,
 
 
  
2022
 
  
2021
 
Current
                 
Federal
   $ 757,069      $ —    
State
     —          —    
Deferred
                 
Federal
     (1,210,347      (349,999
State
  
 
—  
 
  
 
—  
 
Change in valuation allowance

  
 
1,210,347
 
  
 
349,999
 
    
 
 
    
 
 
 
Income tax provision
   $ 757,069      $ —    
    
 
 
    
 
 
 
Summary Of Reconciliation Of The Federal Income Tax Rate(Benefit) And Effective Tax Rate(Benefit)
A reconciliation of the federal income tax rate to the Company’s effective tax rate at December 31, 2022 and 2021 is as follows:

 
 
  
Years Ended December 31,
 
 
  
 2022 
 
 
 2021 
 
Income tax at statutory rate
     21.0     21.0
Change in valuation allowance
     (66.0 )%     8.2
Fair value of warrant adjustment
     3.7     (29.2 )%
 
    
 
 
   
 
 
 
Income tax expense
     (41.3 )%     0.0
    
 
 
   
 
 
 
v3.24.0.1
Organization and Business Operations - Additional Information (Details) - USD ($)
9 Months Ended 12 Months Ended
Aug. 31, 2023
Aug. 29, 2023
Mar. 02, 2023
Feb. 23, 2023
Mar. 01, 2021
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Aug. 22, 2023
Jun. 30, 2023
Feb. 27, 2023
Feb. 06, 2023
Nov. 02, 2022
Oct. 31, 2022
Aug. 16, 2022
Nov. 25, 2020
Proceeds from issuance of IPO               $ 0 $ 281,750,000                
Restricted investments term         185 days                        
Minimum percent of balance in the Trust Account for business combination           80.00%   80.00%                  
Minimum percent of outstanding voting securities owns for business combination           50.00%   50.00%                  
Redemption of shares for a pro rata portion           $ 10   $ 10                  
Minimum tangible assets for business combination           $ 5,000,001   $ 5,000,001                  
Percentage of public shares to be redeemed on non-completion of business combination           100.00%   100.00%                  
Stock price threshold limit           $ 10   $ 10                  
cash           $ 709,450   $ 100,256                  
Proceeds from issuance of common stock               287,500,000 $ 287,500,000                
Amount drew down under updated note               3,218,297                  
Working capital deficit           12,065,413   6,547,305                  
Investment income, interest to pay dissolution expenses           100,000   100,000                  
Payment of taxes               $ 786,918                  
Excise Tax On Certain Repurchases Of Stock Under Inflation Reduction Act                               1.00%  
Amount in the trust account available to be withdrawn           $ 816,118                      
Temporary equity shares outstanding           6,104,682   28,750,000 28,750,000                
Proceeds from sale of restricted investments $ 24,008,096 $ 24,008,096 $ 206,121,060     $ 230,129,156 $ 0 $ 786,918 $ 0                
Temporary equity redemption price per share $ 10.31 $ 10.31 $ 10.15                            
Reduction Of Excise Tax Payable On Redemption           2,308,378                      
Minimum cash threshold previous           200,000,000                      
Minimum cash threshold current           $ 150,000,000                      
Working Capital Loan [Member]                                  
Amount Available Under Promissory Note               800,000                  
Debt instrument drawn               170,000                  
Subsequent Event [Member]                                  
Proceeds from sale of restricted investments       $ 206,121,060                          
Temporary equity redemption price per share     $ 10.15                            
Updated Promissory Note [Member]                                  
Amount Available Under Promissory Note               365,000                  
Debt instrument drawn               335,000                  
Commercial Paper [Member]                                  
Amount Available Under Promissory Note               300,000                 $ 300,000
Commercial Paper [Member] | Updated Promissory Note [Member]                                  
Amount Available Under Promissory Note                                 $ 75,000
Q42022 Promissory Note [Member]                                  
Debt instrument drawn                             $ 200,000    
Sponsor [Member]                                  
Proceeds from issuance of common stock               $ 25,000                  
Sponsor [Member] | Subsequent Event [Member] | Unsecured Loan For Working Capital Purposes [Member]                                  
Amount Available Under Promissory Note                         $ 535,000        
Sponsor [Member] | Private Placement Warrants [Member]                                  
Class of warrants and rights issued during the period         $ 7,750,000                        
Class of warrants and rights issued price per warrant         $ 1                        
Common Class A [Member]                                  
Temporary equity shares outstanding   2,328,063   20,317,255   6,104,682   28,750,000 28,750,000   8,432,745 20,317,255          
Percentage Of Common Stock Issued And Outstanding   27.61%   70.67%               70.67%          
Proceeds from sale of restricted investments           $ 230,129,156                      
Temporary equity redemption price per share           $ 10.34   $ 10.1 $ 10                
Common stock shares issued           7,187,500   0 0                
Common stock shares outstanding           7,187,500   0 0                
Common Class A [Member] | Subsequent Event [Member]                                  
Temporary equity shares outstanding       20,317,255                          
Percentage Of Common Stock Issued And Outstanding       70.67%                          
Common Class A [Member] | Sponsor [Member]                                  
Common stock shares issued                   7,187,500              
Common Class B [Member]                                  
Common stock shares issued           0   7,187,500 7,187,500                
Common stock shares outstanding           0   7,187,500 7,187,500                
Common Class B [Member] | Sponsor [Member]                                  
Common stock shares outstanding                   0              
Common Class B [Member] | Sable Offshore Holdings LLC [Member] | Sable PIPE Subscription Agreements [Member]                                  
Shares issued price per share                           $ 10      
Common Unit, Issued                           7,450,000      
Common Unit, Issuance Value                           $ 74,500,000      
IPO [Member]                                  
Stock issued during period shares         28,750,000                        
Shares issued price per share         $ 10                        
Proceeds from issuance of IPO         $ 287,500,000                        
Stock ìssuance costs                 $ 6,607,751                
Payments for underwriting expense                 5,750,000                
Other offering costs                 857,751                
Offering expenses related to warrant issuance                 $ 280,829                
cash         $ 287,500,000                        
v3.24.0.1
Significant Accounting Policies - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Aug. 31, 2023
Aug. 29, 2023
Mar. 02, 2023
Feb. 23, 2023
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Aug. 22, 2023
Jun. 30, 2023
Feb. 27, 2023
Marketable Securities                 $ 290,718,297 $ 287,516,153      
Federal depository insurance coverage         $ 250,000   $ 250,000   $ 250,000        
Class A common stock subject to possible redemption         6,104,682   6,104,682   28,750,000 28,750,000      
Offering cost                 $ 6,607,751        
Underwriting fee on issuance of common stock                 5,750,000        
Other offering cost                 857,751        
Offering cost reclassified as non-operating expense                 $ 280,829        
Common stock warrants issued         22,125,000   22,125,000   22,125,000        
Cash equivalents         $ 0   $ 0   $ 0 $ 0      
Statutory rate         21.00% 21.00% 21.00% 21.00% 21.00% 21.00%      
Proceeds from Interest Received             $ 490,151   $ 786,918 $ 0      
Proceeds from Sale of Restricted Investments $ 24,008,096 $ 24,008,096 $ 206,121,060       $ 230,129,156 $ 0 $ 786,918 $ 0      
Temporary Equity Redemption Price Per Share $ 10.31 $ 10.31 $ 10.15                    
Effective tax rate         (1.42%) (156.66%) (30.08%) (5.53%)          
Subsequent Event [Member]                          
Proceeds from Sale of Restricted Investments       $ 206,121,060                  
Temporary Equity Redemption Price Per Share     $ 10.15                    
Common Class A [Member]                          
Class A common stock subject to possible redemption   2,328,063   20,317,255 6,104,682   6,104,682   28,750,000 28,750,000   8,432,745 20,317,255
Common stock warrants issued         25,431,370 23,625,000 25,431,370 23,625,000 23,625,000 23,290,000      
Proceeds from Sale of Restricted Investments             $ 230,129,156            
Temporary Equity Redemption Price Per Share         $ 10.34   $ 10.34   $ 10.1 $ 10      
Common stock shares issued         7,187,500   7,187,500   0 0      
Common stock shares outstanding         7,187,500   7,187,500   0 0      
Common Class A [Member] | Sponser [Member]                          
Common stock shares issued                     7,187,500    
Common Class A [Member] | Subsequent Event [Member]                          
Class A common stock subject to possible redemption       20,317,255                  
Common Class B [Member]                          
Common stock shares issued         0   0   7,187,500 7,187,500      
Common stock shares outstanding         0   0   7,187,500 7,187,500      
Common Class B [Member] | Sponser [Member]                          
Common stock shares outstanding                     0    
IPO [Member]                          
Common stock warrants issued         14,375,000   14,375,000   14,375,000        
Private Placement [Member]                          
Common stock warrants issued         7,750,000   7,750,000   7,750,000        
v3.24.0.1
Significant Accounting Policies - Summary of Reconciled the Class A Ordinary Shares (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Temporary Equity [Line Items]        
Gross proceeds from Initial Public Offering, Shares     28,750,000  
Contingently redeemable common stock, Shares 6,104,682   28,750,000 28,750,000
Redemptions of Class A common stock, Shares (22,645,318)      
Gross proceeds from Initial Public Offering     $ 287,500,000 $ 287,500,000
Common stock issuance costs     (6,326,922) (6,326,922)
Proceeds allocated to public warrants     (12,218,750) (12,218,750)
Redemptions of Class A common stock $ (230,129,156) $ 0    
Remeasurement of Class A common stock subject to possible redemption 2,905,703   21,392,680 18,545,672
Contingently redeemable ordinary shares $ 63,123,555   290,347,008 $ 287,500,000
Remeasurement of Class A common stock subject to possible redemption [Member]        
Temporary Equity [Line Items]        
Remeasurement of Class A common stock subject to possible redemption     $ 2,847,008  
v3.24.0.1
Significant Accounting Policies - Summary of Net Income Per Share of Common Stock (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Common Class A [Member] | Redeemable Common Stock [Member]            
Numerator [Abstract]            
Net (loss) income allocable $ (5,571,661) $ (153,400) $ (2,167,037) $ 7,243,954 $ (2,072,758) $ 3,301,319
Denominator [Abstract]            
Weighted average shares outstanding, basic 8,169,859 28,750,000 12,660,640 28,750,000 28,750,000 24,417,808
Weighted average shares outstanding, diluted 8,169,859 28,750,000 12,660,640 28,750,000 28,750,000 24,417,808
Basic, net (loss) income per share $ (0.68) $ (0.01) $ (0.17) $ 0.25 $ (0.07) $ 0.14
Diluted, net (loss) income per share $ (0.68) $ (0.01) $ (0.17) $ 0.25 $ (0.07) $ 0.14
Common Class B [Member] | Non Redeemable Common Stock [Member]            
Numerator [Abstract]            
Net (loss) income allocable         $ (518,190) $ 971,759
Denominator [Abstract]            
Weighted average shares outstanding, basic         7,187,500  
Weighted average shares outstanding, diluted           7,187,500
Basic, net (loss) income per share         $ (0.07) $ 0.14
Diluted, net (loss) income per share         $ (0.07) $ 0.14
Common Class A And Class B [Member] | Non Redeemable Common Stock [Member]            
Numerator [Abstract]            
Net (loss) income allocable $ (4,901,714) $ (38,350) $ (1,230,237) $ 1,810,988    
Denominator [Abstract]            
Weighted average shares outstanding, basic 7,187,500 7,187,500 7,187,500 7,187,500    
Weighted average shares outstanding, diluted 7,187,500 7,187,500 7,187,500 7,187,500    
Basic, net (loss) income per share $ (0.68) $ (0.01) $ (0.17) $ 0.25    
Diluted, net (loss) income per share $ (0.68) $ (0.01) $ (0.17) $ 0.25    
v3.24.0.1
Initial Public Offering - Additional Information (Details)
Mar. 01, 2021
$ / shares
shares
Sep. 30, 2023
shares
$ / shares
Dec. 31, 2022
shares
$ / shares
Dec. 31, 2021
$ / shares
Subsidiary, Sale of Stock [Line Items]        
Number of class A common stocks included in each unit   1 1  
Number of public warrants that each unit consists (in shares)   0.5 0.5  
Common Class A [Member]        
Subsidiary, Sale of Stock [Line Items]        
Common stock par or stated value per share | $ / shares   $ 0.0001 $ 0.0001 $ 0.0001
Common Class A [Member] | Public Warrants [Member]        
Subsidiary, Sale of Stock [Line Items]        
Shares issuable per whole warrant   1 1  
Exercise price of warrant | $ / shares $ 11.5      
IPO [Member]        
Subsidiary, Sale of Stock [Line Items]        
Sale of Units in Initial Public Offering (Shares) 28,750,000      
Shares issued price per share | $ / shares $ 10      
Common stock par or stated value per share | $ / shares   $ 0.0001 $ 0.0001  
Over-Allotment Option [Member]        
Subsidiary, Sale of Stock [Line Items]        
Sale of Units in Initial Public Offering (Shares) 3,750,000      
v3.24.0.1
Private Placement Warrants - Additional Information (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Sep. 30, 2023
Dec. 31, 2022
Private Placement Warrants [Member]      
Class of Warrant or Right [Line Items]      
Adjustment to additional paid in capital warrants issued $ 1,166,375    
Private Placement [Member]      
Class of Warrant or Right [Line Items]      
Number of warrants issued   7,750,000 7,750,000
Number of warrants issued, price per warrant   $ 1 $ 1
Aggreagate value of warrants issued   $ 7,750,000 $ 7,750,000
Warrants issued, exercise price   $ 11.5 $ 11.5
Number of Class A common stock that can be purchased per warrant   1 1
v3.24.0.1
Related Party Transactions - Schedule Of Fair Value Of Debt Instrument (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Converible Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure $ 2,645,096 $ 1,409,730
Principal Value 3,306,370  
Promissory Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 1,128,630 370,000
Principal Value 1,128,630  
First Working Capital Loan [Member] | Converible Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 292,000 343,034
Principal Value 365,000  
Second Working Capital Loan [Member] | Converible Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 640,000 751,856
Principal Value 800,000  
Third Working Capital Loan [Member] | Converible Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 268,000 314,840
Principal Value 335,000  
Q3 2022 Promissory Note [Member] | Converible Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 136,000 0
Principal Value 170,000  
Q3 2022 Promissory Note [Member] | Promissory Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 0 170,000
Principal Value 0  
Q42022 Promissory Note [Member] | Converible Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 160,000 0
Principal Value 200,000  
Q42022 Promissory Note [Member] | Promissory Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 0 200,000
Principal Value 0  
Q12023 Promissory Note [Member] | Converible Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 285,096 0
Principal Value 356,370  
Q12023 Promissory Note [Member] | Promissory Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 178,630 0
Principal Value 178,630  
First Q3 2023 Promissory Note [Member] | Converible Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 508,000 0
Principal Value 635,000  
Second Q3 2023 Promissory Note [Member] | Promissory Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 495,000 0
Principal Value 495,000  
First Q22023 Promissory Note [Member] | Converible Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 316,000 0
Principal Value 395,000  
Third Q22023 Promissory Note [Member] | Promissory Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 100,000 0
Principal Value 100,000  
Fourth Q22023 Promissory Note [Member] | Converible Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 40,000 0
Principal Value 50,000  
Second Q22023 Promissory Note [Member] | Promissory Notes [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Fair Value Disclosure 355,000 $ 0
Principal Value $ 355,000  
v3.24.0.1
Related Party Transactions - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Nov. 14, 2023
May 31, 2023
Mar. 29, 2023
Feb. 06, 2023
Nov. 30, 2020
Sep. 30, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Aug. 30, 2023
Aug. 22, 2023
Jun. 30, 2023
Jun. 22, 2023
May 12, 2023
Mar. 31, 2023
Mar. 28, 2023
Mar. 24, 2023
Mar. 03, 2023
Oct. 31, 2022
Mar. 31, 2022
Mar. 29, 2022
Dec. 31, 2021
Dec. 27, 2021
Jun. 30, 2021
Mar. 01, 2021
Nov. 25, 2020
Related Party Transaction [Line Items]                                                    
Related party transaction terms and manner of settlement             of our Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property, the converted Class A common stock will be released from the lock-up.   for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property, the converted Class A common stock will be released from the lock-up.                                  
Line of credit outstanding                 $ 365,000                                  
Debt Instrument Drawn           $ 365,000 $ 365,000   365,000                                  
Proceed from convertible debt             1,080,000 $ 335,000                                    
Notes payable, fair value disclosure           $ 316,000 $ 316,000                                      
Commercial Paper [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument face amount                 $ 300,000                                 $ 300,000
Promissory note interest bearing                                                   0.00%
Promissory note payment terms                 May 25, 2021                                  
Q12023 Promissory Note [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument drawn       $ 535,000                                            
Proceeds From Notes Payable       356,370                                            
Q12023 Promissory Note [Member] | Subsequent Event [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument drawn       $ 535,000                                            
Common Class B [Member]                                                    
Related Party Transaction [Line Items]                                                    
Common stock shares issued           0 0   7,187,500                         7,187,500        
Common stock shares outstanding           0 0   7,187,500                         7,187,500        
Common Class A [Member]                                                    
Related Party Transaction [Line Items]                                                    
Common stock shares issued           7,187,500 7,187,500   0                         0        
Common stock shares outstanding           7,187,500 7,187,500   0                         0        
Working Capital Loans [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument convertible conversion price           $ 1 $ 1   $ 1         $ 1                        
Fair value estimated by the Company           $ 684,165 $ 684,165                                      
Working capital loans                             $ 0                      
Working Capital Loans [Member] | Minimum [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument convertible conversion amount                                 $ 1,500,000                  
Working Capital Loans [Member] | Maximum [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument convertible conversion amount                                 3,500,000                  
Working Capital Loans [Member] | Subsequent Event [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument convertible conversion price                               $ 1                    
Working Capital Loans [Member] | Subsequent Event [Member] | Minimum [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument convertible conversion amount                                 1,500,000 $ 1,500,000                
Working Capital Loans [Member] | Subsequent Event [Member] | Maximum [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument convertible conversion amount                                 $ 3,500,000 $ 3,500,000                
First Working Capital Loan [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument face amount                                                 $ 365,000  
Promissory note interest bearing                                                 0.00%  
Fair value estimated by the Company           292,000 292,000   $ 343,034                         $ 299,555        
Fair value at initial measurement                 383,323                               $ 383,323  
Second Working Capital Loan [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument face amount                                             $ 800,000      
Promissory note interest bearing                                             0.00%      
Debt Instrument Drawn                                             $ 800,000      
Debt Instrument Outstanding                 800,000                                  
Fair value estimated by the Company           640,000 640,000   751,856                                  
Fair value at initial measurement                                           $ 656,560        
Third Working Capital Loan [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument face amount                                         $ 335,000          
Promissory note interest bearing                                         0.00%          
Debt Instrument Drawn           335,000 335,000   335,000                                  
Debt Instrument Outstanding                 335,000                                  
Fair value estimated by the Company           $ 268,000 $ 268,000   314,840                                  
Fair value at initial measurement                 $ 282,874                     $ 282,874            
Founders [Member] | Common Class B [Member] | Founder Shares [Member]                                                    
Related Party Transaction [Line Items]                                                    
Stock issued during period, Value         $ 25,000                                          
Shares issued price per share         $ 0.0035                                          
Stock issued during period, Shares         7,187,500                                          
Sponser [Member] | Share Price More Than Or Equals To USD Twelve [Member]                                                    
Related Party Transaction [Line Items]                                                    
Share transfer, trigger price price per share           $ 12 $ 12   $ 12                                  
Number of consecutive trading days for determining share price             20 days   20 days                                  
Number of trading days for determining share price             30 days   30 days                                  
Threshold number of trading days for determining share price from date of business combination             150 days   150 days                                  
Sponser [Member] | Common Class B [Member]                                                    
Related Party Transaction [Line Items]                                                    
Stock issued during period, Shares         4,671,875                                          
Transfer of stock shares transferred         434,375                                          
Common stock shares outstanding                     0                              
Sponser [Member] | Common Class A [Member]                                                    
Related Party Transaction [Line Items]                                                    
Common stock shares issued                     7,187,500                              
Sponser [Member] | Working Capital Loans [Member] | Chief Financial Officer [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument value assigned                                                 145,000  
Sponser [Member] | Working Capital Loans [Member] | Vice President [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument value assigned                                                 $ 110,000  
Sponser [Member] | Third Working Capital Loan [Member] | Chief Financial Officer [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument value assigned           $ 111,667 $ 111,667                                      
Sponser [Member] | Third Working Capital Loan [Member] | Vice President [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument value assigned           111,667 111,667                                      
Sponser [Member] | Third Working Capital Loan [Member] | General Counsel And Secretary [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument value assigned           111,666 111,666                                      
FL Co Investment [Member] | Common Class B [Member]                                                    
Related Party Transaction [Line Items]                                                    
Stock issued during period, Shares         1,257,813                                          
Transfer of stock shares transferred         13,125                                          
Intrepid Financial Partners [Member] | Common Class B [Member]                                                    
Related Party Transaction [Line Items]                                                    
Stock issued during period, Shares         1,257,812                                          
Related Party [Member] | Working Capital Loans [Member]                                                    
Related Party Transaction [Line Items]                                                    
Working capital loans                 $ 0           $ 0                      
Q12023 Promissory Note [Member]                                                    
Related Party Transaction [Line Items]                                                    
Proceeds From Notes Payable   $ 356,370                                                
Q42022 Promissory Note [Member] | Working Capital Loans [Member]                                                    
Related Party Transaction [Line Items]                                                    
Proceed from convertible debt     $ 726,370                                              
Convertibe Notes And Promissory Note [Member] | Working Capital Loans [Member]                                                    
Related Party Transaction [Line Items]                                                    
Class of warrants or rights convertble into equity value           $ 3,306,370 $ 3,306,370                                      
Class of warrants or rights number of warrants convertible into equity           3,306,370 3,306,370                                      
Updated Promissory Note [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument face amount                 365,000                                  
Debt instrument drawn                 $ 335,000                                  
Updated Promissory Note [Member] | Commercial Paper [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument face amount                                                   $ 75,000
Outstanding borrowings amount                                               $ 0    
Promissory Note [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument face amount               $ 170,000                     $ 200,000              
Promissory Note [Member] | Merger Agreement [Member]                                                    
Related Party Transaction [Line Items]                                                    
Transaction cost           $ 1,500,000 $ 1,500,000                                      
Payments for acquisition             3,000,000                                      
Advances to acquisition target           123,897 726,868                                      
Promissory Note [Member] | Subsequent Event [Member] | Merger Agreement [Member]                                                    
Related Party Transaction [Line Items]                                                    
Advances to acquisition target $ 106,000                                                  
Promissory Note [Member] | Q12023 Promissory Note [Member]                                                    
Related Party Transaction [Line Items]                                                    
Fair value estimated by the Company           285,096 285,096                                      
Promissory Note [Member] | First Q22023 Promissory Note [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument face amount                           $ 395,000                        
Fair value at initial measurement           229,653 229,653                                      
Promissory Note [Member] | Second Q22023 Promissory Note [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument face amount                           $ 355,000                        
Promissory Note [Member] | Third Q22023 Promissory Note [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument face amount                         $ 100,000                          
Promissory Note [Member] | Fourth Q22023 Promissory Note [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument face amount                         $ 50,000                          
Fair value at initial measurement           40,000 40,000         $ 29,150                            
Promissory Note [Member] | Q3 2022 Promissory Note [Member]                                                    
Related Party Transaction [Line Items]                                                    
Fair value estimated by the Company           136,000 136,000                                      
Promissory Note [Member] | Q42022 Promissory Note [Member]                                                    
Related Party Transaction [Line Items]                                                    
Fair value estimated by the Company           160,000 160,000                                      
Promissory Note [Member] | Second Q3 2023 Promissory Note [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument face amount                   $ 495,000                                
Fair value estimated by the Company           508,000 508,000                                      
Fair value at initial measurement           $ 330,199 $ 330,199                                      
Promissory Note [Member] | First Q3 2023 Promissory Note [Member]                                                    
Related Party Transaction [Line Items]                                                    
Debt instrument face amount                   $ 635,000                                
v3.24.0.1
Commitments And Contingencies - Additional Information (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Aug. 29, 2023
Jun. 30, 2023
Feb. 27, 2023
Feb. 23, 2023
Dec. 31, 2021
Commitments and Contingencies [Line Items]              
Underwriting discount per share $ 0.2 $ 0.2          
Adjustment to additional paid in capital underwriting discount $ 5,750,000 $ 5,750,000          
Percentage of gross proceeds of the IPO payable to Underwriters as Marketing Fee 3.50% 3.50%          
Deferred Legal Fees             $ 0
Temporary equity shares outstanding 6,104,682 28,750,000         28,750,000
Percentage Of Underwriting Commissions Charged To Proceeds From IPO 15.90%            
Common Class A [Member]              
Commitments and Contingencies [Line Items]              
Temporary equity shares outstanding 6,104,682 28,750,000 2,328,063 8,432,745 20,317,255 20,317,255 28,750,000
Percentage Of Common Stock Issued And Outstanding     27.61%   70.67% 70.67%  
Second Extension [Member] | Common Class A [Member]              
Commitments and Contingencies [Line Items]              
Temporary equity shares outstanding 6,104,682         2,328,063  
Percentage Of Common Stock Issued And Outstanding           27.61%  
Unbilled Expenses [Member]              
Commitments and Contingencies [Line Items]              
Deferred Legal Fees $ 3,623,594 $ 2,633,139          
v3.24.0.1
Stockholders' Deficit - Additional Information (Details) - USD ($)
9 Months Ended 12 Months Ended
Aug. 31, 2023
Aug. 29, 2023
Mar. 02, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Aug. 22, 2023
Jun. 30, 2023
Feb. 27, 2023
Feb. 23, 2023
Class of Stock [Line Items]                      
Preferred stock par or stated value per share       $ 0.0001   $ 0.0001 $ 0.0001        
Preferred stock shares authorized       1,000,000   1,000,000 1,000,000        
Preferred stock shares issued       0   0 0        
Preferred stock shares outstanding       0   0 0        
Temporary equity shares outstanding       6,104,682   28,750,000 28,750,000        
Proceeds from Sale of Restricted Investments $ 24,008,096 $ 24,008,096 $ 206,121,060 $ 230,129,156 $ 0 $ 786,918 $ 0        
Temporary Equity Redemption Price Per Share $ 10.31 $ 10.31 $ 10.15                
Common Class A [Member]                      
Class of Stock [Line Items]                      
Common stock par or stated value per share       $ 0.0001   $ 0.0001 $ 0.0001        
Common stock shares authorized       200,000,000   200,000,000 200,000,000        
Common stock shares issued       7,187,500   0 0        
Common stock shares outstanding       7,187,500   0 0        
Temporary equity shares outstanding   2,328,063   6,104,682   28,750,000 28,750,000   8,432,745 20,317,255 20,317,255
Common stock, voting rights           one          
Proceeds from Sale of Restricted Investments       $ 230,129,156              
Temporary Equity Redemption Price Per Share       $ 10.34   $ 10.1 $ 10        
Common Class A [Member] | Sponser [Member]                      
Class of Stock [Line Items]                      
Common stock shares issued               7,187,500      
Common Class B [Member]                      
Class of Stock [Line Items]                      
Common stock par or stated value per share       $ 0.0001   $ 0.0001 $ 0.0001        
Common stock shares authorized       20,000,000   20,000,000 20,000,000        
Common stock shares issued       0   7,187,500 7,187,500        
Common stock shares outstanding       0   7,187,500 7,187,500        
Common stock, voting rights           one          
Common Class B [Member] | Sponser [Member]                      
Class of Stock [Line Items]                      
Common stock shares outstanding               0      
Common Class B [Member] | Determination Of Price Of Class A Common Stock For A Certain Period Based On Which Lock In Period Of Class B Common Stock Will Be Determined [Member]                      
Class of Stock [Line Items]                      
Lock in period of shares           1 year          
Share price       $ 12   $ 12          
Number of trading days for determining the share price       20 days   20 days          
Number of consecutive trading days for determining the share price       30 days   30 days          
Waiting period after which price of share is determined post business combination       150 days   150 days          
v3.24.0.1
Warrants - Additional Information (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Mar. 24, 2023
Maximum [Member] | Working Capital Loan [Member]      
Warrants [Line Items]      
Debt Instrument, Convertible, Carrying Amount of Equity Component     $ 3,500,000
Maximum [Member] | Subsequent Event [Member] | Working Capital Loan [Member]      
Warrants [Line Items]      
Debt Instrument, Convertible, Carrying Amount of Equity Component     3,500,000
Minimum [Member] | Working Capital Loan [Member]      
Warrants [Line Items]      
Debt Instrument, Convertible, Carrying Amount of Equity Component     1,500,000
Minimum [Member] | Subsequent Event [Member] | Working Capital Loan [Member]      
Warrants [Line Items]      
Debt Instrument, Convertible, Carrying Amount of Equity Component     $ 1,500,000
Public Warrants [Member]      
Warrants [Line Items]      
Class of warrants or rights days after which warrants are excercisable post consummation of business combination 30 days 30 days  
Class of warrants or rights days after which warrants are excercisable post initial public offer 12 months 12 months  
Class of warrants or rights term 5 years 5 years  
Number of days after business combination within which securities shall be registered 15 days 15 days  
Number of days after business combination within which the registration of securities shall be effective 60 days 60 days  
Exercise price payable for the warrant $ 0.361 $ 0.361  
Lock in period of warrants 30 days 30 days  
Public Warrants [Member] | Prospective Warrant Redemption [Member]      
Warrants [Line Items]      
Sale of stock, price per share $ 9.2 $ 9.2  
Proceeds to be used for business combination as a percentage of total capital to be raised 60.00% 60.00%  
Number of trading days for determining volume weighted average price of the shares 20 days 20 days  
Volume weighted average price per share $ 9.2 $ 9.2  
Public Warrants [Member] | Prospective Warrant Redemption [Member] | Trigger Price One [Member]      
Warrants [Line Items]      
Exercise price of warrants as a percentage of newly issued share price 180.00% 180.00%  
Share price $ 10 $ 10  
Public Warrants [Member] | Prospective Warrant Redemption [Member] | Trigger Price Two [Member]      
Warrants [Line Items]      
Exercise price of warrants as a percentage of newly issued share price 115.00% 115.00%  
Share price $ 18 $ 18  
Public Warrants [Member] | Prospective Warrant Redemption [Member] | Redemption Of Warrants For Cash [Member]      
Warrants [Line Items]      
Class of warrants or rights redemption price per unit of warrant $ 0.01 $ 0.01  
Minimum number of days of notice to be given to warrant holders prior to redemption 30 days 30 days  
Newly adjusted issue price per share $ 18 $ 18  
Number of trading days for determining the newly issued share price 20 days 20 days  
Number of consecutive trading days for determining the newly issued share price 30 days 30 days  
Public Warrants [Member] | Prospective Warrant Redemption [Member] | Redemption Of Warrants For Class A Common Stock [Member]      
Warrants [Line Items]      
Minimum number of days of notice to be given to warrant holders prior to redemption 30 days 30 days  
Newly adjusted issue price per share $ 10 $ 10  
Number of days after which the redemption period commences after the warrant becomes exercisable 90 days 90 days  
v3.24.0.1
Fair Value Measurements - Schedule of Assets Measured at Fair Value on a Recurring Basis (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Assets:      
U.S. Money Market and Treasury Securities Held in Trust Account $ 63,939,672 $ 290,718,297 $ 287,516,153
Liabilities:      
Convertible Promissory Notes—Related Parties 316,000    
Fair Value, Recurring [Member] | Level 1 [Member] | Public Warrants [Member]      
Liabilities:      
Fair value liabilities 11,500,000 9,343,750 8,625,000
Fair Value, Recurring [Member] | Level 1 [Member] | U.S. Money Market and Treasury Securities Held in Trust Account [Member]      
Assets:      
U.S. Money Market and Treasury Securities Held in Trust Account   290,718,297 287,516,153
Fair Value, Recurring [Member] | Level 1 [Member] | U.S. Money Market Funds Held in Trust Account [Member]      
Assets:      
U.S. Money Market and Treasury Securities Held in Trust Account 0 290,718,297  
Fair Value, Recurring [Member] | Level 3 [Member]      
Liabilities:      
Convertible Promissory Notes—Related Parties 2,645,096 1,409,730 956,115
Fair Value, Recurring [Member] | Level 3 [Member] | Private Warrants [Member]      
Liabilities:      
Fair value liabilities $ 3,654,125 $ 2,805,500 $ 4,022,250
v3.24.0.1
Fair Value Measurements - Schedule of Fair Value Measurements Using Monte Carlo Simulation Model (Details) - Level 3 [Member]
Sep. 30, 2023
yr
Dec. 31, 2022
yr
Dec. 31, 2021
yr
Exercise price [Member] | Other Private Placement Warrants [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Warrants and rights outstanding 11.5 11.5 11.5
Volatility [Member] | Other Private Placement Warrants [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Warrants and rights outstanding 0 0 10.8
Risk-free rate [Member] | Other Private Placement Warrants [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Warrants and rights outstanding 4.82 4.12 1.13
Dividend yield [Member] | Other Private Placement Warrants [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Warrants and rights outstanding 0 0 0
Stock price [Member] | Other Private Placement Warrants [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Warrants and rights outstanding 10.46 10.05 9.72
Time to Expiration (in years) [Member] | Other Private Placement Warrants [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Warrants and rights outstanding 2.4 3.15 4.15
Promissory Note [Member] | Exercise price [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Securities available for sale 11.5 11.5 11.5
Promissory Note [Member] | Volatility [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Securities available for sale 2.5 1.2 12.9
Promissory Note [Member] | Volatility [Member] | Maximum [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Securities available for sale 2.5    
Promissory Note [Member] | Volatility [Member] | Minimum [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Securities available for sale 1.9    
Promissory Note [Member] | Expected term to warrant expiration [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Securities available for sale 5.3 5.3 5.4
Promissory Note [Member] | Expected term to warrant expiration [Member] | Maximum [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Securities available for sale 5.6    
Promissory Note [Member] | Expected term to warrant expiration [Member] | Minimum [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Securities available for sale 5.2    
Promissory Note [Member] | Risk-free rate [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Securities available for sale 4.5 3.91 1.32
Promissory Note [Member] | Risk-free rate [Member] | Maximum [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Securities available for sale 4.17    
Promissory Note [Member] | Risk-free rate [Member] | Minimum [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Securities available for sale 3.39    
Promissory Note [Member] | Dividend yield [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Securities available for sale 0 0 0
Promissory Note [Member] | Stock price [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Securities available for sale 10.46 10.05 9.71
Promissory Note [Member] | Stock price [Member] | Maximum [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Securities available for sale 10.39    
Promissory Note [Member] | Stock price [Member] | Minimum [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Securities available for sale 10.13    
Convertible Promissory Notes Related Parties [Member] | Exercise price [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Warrants and rights outstanding 11.5 11.5 11.5
Convertible Promissory Notes Related Parties [Member] | Volatility [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Warrants and rights outstanding 0 0 10.8
Convertible Promissory Notes Related Parties [Member] | Expected term to warrant expiration [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Warrants and rights outstanding 5.3 5.25 5.42
Convertible Promissory Notes Related Parties [Member] | Risk-free rate [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Warrants and rights outstanding 4.5 3.91 1.29
Convertible Promissory Notes Related Parties [Member] | Dividend yield [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Warrants and rights outstanding 0 0 0
Convertible Promissory Notes Related Parties [Member] | Stock price [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Warrants and rights outstanding 10.46 10.05 9.72
v3.24.0.1
Fair Value Measurements - Schedule of Changes in the Fair Value of Warrant Liabilities (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 29, 2021
Aug. 11, 2021
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Mar. 01, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                            
Proceeds received through Convertible Promissory Notes                   $ 1,080,000 $ 335,000      
Change in fair value of Promissory Notes     $ 757,488       $ (1,200)     (37,804) 21,011 $ 170,741 $ (83,768)  
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]     Fair Value Adjustment of Warrants                 Fair Value Adjustment of Warrants    
Convertible Promissory Notes Related Parties [Member]                            
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                            
Fair value     $ 1,557,409 $ 2,097,015 $ 1,409,730 $ 1,260,000 1,261,200 $ 1,266,600 $ 956,115 1,409,730 956,115 $ 956,115 0  
Principal amount of Promissory Notes         726,370                  
Initial measurement of fair value of Promissory Notes upon extinguishment of debt $ (143,440) $ 18,323 (304,801) (186,194) (42,205) (52,126)     (52,126) (304,801)   (52,126)    
Proceeds received through Convertible Promissory Notes $ 800,000 $ 365,000 635,000 445,000         335,000     335,000    
Change in fair value of Promissory Notes     757,488 (798,412) 3,120 149,730 (1,200) (5,400) 27,611     170,741 (83,768)  
Fair value     2,645,096 1,557,409 2,097,015 1,409,730 1,260,000 1,261,200 1,266,600 2,645,096 1,260,000 1,409,730 956,115  
Public [Member]                            
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                            
Fair value     4,456,250 8,193,750 9,343,750 2,012,500 2,300,000 4,168,750 8,625,000 9,343,750 8,625,000 8,625,000 0  
Initial measurement of fair value of Promissory Notes upon extinguishment of debt                           $ 12,218,750
Change in valuation inputs or other assumptions     7,043,750 (3,737,500) (1,150,000)   (287,500) (1,868,750) (4,456,250)     718,750 (3,593,750)  
Fair value     11,500,000 4,456,250 8,193,750 9,343,750 2,012,500 2,300,000 4,168,750 11,500,000 2,012,500 9,343,750 8,625,000  
Private Placement [Member]                            
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                            
Fair value     1,426,000 2,604,000 2,805,500 631,625 716,875 1,619,750 4,022,250 2,805,500 4,022,250 4,022,250 0  
Initial measurement of fair value of Promissory Notes upon extinguishment of debt                           6,583,625
Change in valuation inputs or other assumptions     2,228,125 (1,178,000) (201,500)   (85,250) (902,875) (2,402,500)     (1,216,750) (2,561,375)  
Fair value     3,654,125 1,426,000 2,604,000 2,805,500 631,625 716,875 1,619,750 3,654,125 631,625 2,805,500 4,022,250  
Warrant Liabilities [Member]                            
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                            
Fair value     5,882,250 10,797,750 12,149,250 2,644,125 3,016,875 5,788,500 12,647,250 12,149,250 12,647,250 12,647,250 0  
Initial measurement of fair value of Promissory Notes upon extinguishment of debt                           $ 18,802,375
Change in valuation inputs or other assumptions     9,271,875 (4,915,500) (1,351,500)   (372,750) (2,771,625) (6,858,750)     (498,000) (6,155,125)  
Fair value     $ 15,154,125 $ 5,882,250 $ 10,797,750 $ 12,149,250 $ 2,644,125 $ 3,016,875 $ 5,788,500 $ 15,154,125 $ 2,644,125 $ 12,149,250 $ 12,647,250  
v3.24.0.1
Fair Value Measurements - Additional Information (Details) - USD ($)
3 Months Ended 12 Months Ended
Apr. 19, 2021
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
U.S. Money Market and Treasury Securities Held in Trust Account   $ 63,939,672   $ 290,718,297 $ 287,516,153
Promissory Note [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member]          
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers, Net   $ 0 $ 0 $ 0 $ 0
Public [Member]          
Transfer from level 3 to level one $ 15,381,250        
v3.24.0.1
Income Tax - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Line Items]              
Change in the valuation allowance         $ 1,210,347 $ 349,999  
Income Tax Expense (Benefit) $ 146,980 $ 530,156 $ 785,543 $ 530,156 757,069 0  
Unrecognized Tax Benefits         0 $ 0  
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued         $ 0    
Effective Income Tax Rate Reconciliation, Percent         (41.30%) 0.00%  
Open Tax Year           2021 2020
TX [Member]              
Income Tax Disclosure [Line Items]              
Effective Income Tax Rate Reconciliation, Percent         0.00%    
Domestic Tax Authority [Member] | UNITED STATES              
Income Tax Disclosure [Line Items]              
Operating loss carryforward,net Federal         $ 0 $ 186,642  
v3.24.0.1
Income Tax - Summary of Net Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Deferred tax asset    
Start-up/organization costs $ 1,560,694 $ 311,152
Net operating loss carryforwards 0 39,195
Total deferred tax assets 1,560,694 350,347
Valuation allowance (1,560,694) (350,347)
Deferred tax asset, net of allowance $ 0 $ 0
v3.24.0.1
Income Tax - Summary Of Income Tax Provision (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]            
Current Federal         $ 757,069 $ 0
Current State         0 0
Deferred Federal         (1,210,347) (349,999)
Deferred State         0 0
Change in valuation allowance         1,210,347 349,999
Income tax provision $ 146,980 $ 530,156 $ 785,543 $ 530,156 $ 757,069 $ 0
v3.24.0.1
Income Tax - Summary Of Reconciliation Of The Federal Income Tax Rate(Benefit) And Effective Tax Rate(Benefit) (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]            
Income tax at statutory rate 21.00% 21.00% 21.00% 21.00% 21.00% 21.00%
Change in valuation allowance         (66.00%) 8.20%
Fair value of warrant adjustment         3.70% (29.20%)
Income tax Expense         (41.30%) 0.00%
v3.24.0.1
Subsequent Events - Additional Information (Details) - USD ($)
9 Months Ended 12 Months Ended
Aug. 31, 2023
Aug. 29, 2023
Mar. 02, 2023
Feb. 23, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Jun. 30, 2023
May 12, 2023
Mar. 28, 2023
Mar. 24, 2023
Mar. 03, 2023
Feb. 27, 2023
Feb. 06, 2023
Subsequent Event [Line Items]                              
Temporary equity shares outstanding         6,104,682   28,750,000 28,750,000              
Proceeds from sale of restricted investments $ 24,008,096 $ 24,008,096 $ 206,121,060   $ 230,129,156 $ 0 $ 786,918 $ 0              
Temporary equity redemption price per share $ 10.31 $ 10.31 $ 10.15                        
Working Capital Loans [Member]                              
Subsequent Event [Line Items]                              
Debt instrument convertible conversion price         $ 1   $ 1     $ 1          
Working Capital Loans [Member] | Maximum [Member]                              
Subsequent Event [Line Items]                              
Debt instrument convertible carrying amount of the equity component                       $ 3,500,000      
Working Capital Loans [Member] | Minimum [Member]                              
Subsequent Event [Line Items]                              
Debt instrument convertible carrying amount of the equity component                       1,500,000      
Q12023 Promissory Note [Member]                              
Subsequent Event [Line Items]                              
Debt instrument drawn                             $ 535,000
Common Class A [Member]                              
Subsequent Event [Line Items]                              
Temporary equity shares outstanding   2,328,063   20,317,255 6,104,682   28,750,000 28,750,000 8,432,745         20,317,255  
Percentage Of Common Stock Issued And Outstanding   27.61%   70.67%                   70.67%  
Proceeds from sale of restricted investments         $ 230,129,156                    
Temporary equity redemption price per share         $ 10.34   $ 10.1 $ 10              
Subsequent Event [Member]                              
Subsequent Event [Line Items]                              
Proceeds from sale of restricted investments       $ 206,121,060                      
Temporary equity redemption price per share     $ 10.15                        
Subsequent Event [Member] | Working Capital Loans [Member]                              
Subsequent Event [Line Items]                              
Debt instrument convertible conversion price                     $ 1        
Subsequent Event [Member] | Working Capital Loans [Member] | Maximum [Member]                              
Subsequent Event [Line Items]                              
Debt instrument convertible carrying amount of the equity component                       3,500,000 $ 3,500,000    
Subsequent Event [Member] | Working Capital Loans [Member] | Minimum [Member]                              
Subsequent Event [Line Items]                              
Debt instrument convertible carrying amount of the equity component                       $ 1,500,000 $ 1,500,000    
Subsequent Event [Member] | Q12023 Promissory Note [Member]                              
Subsequent Event [Line Items]                              
Debt instrument drawn                             $ 535,000
Subsequent Event [Member] | Common Class A [Member]                              
Subsequent Event [Line Items]                              
Temporary equity shares outstanding       20,317,255                      
Percentage Of Common Stock Issued And Outstanding       70.67%